Expandable fusion device for positioning between adjacent vertebral bodies

Abstract
In some embodiments, system and/or method may include an intervertebral implant for a human spine including an upper body, a lower body, first and second expansion members, and an expansion mechanism. A superior surface of the upper body may function to engage a first vertebra of the human spine. An inferior surface of the lower body may function to engage a second vertebra of the human spine. The first expansion member may include at least a first angled portion positionable, during use, between the upper body and the lower body. The second expansion member may include at least a second angled portion positionable, during use, between the upper body and the lower body. An expansion mechanism may convey, during use, the first and second angled portions in opposing directions increasing a separation distance between the upper body and the lower body.
Description
BACKGROUND OF THE INVENTION
1. Field of the Invention

This invention relates to spinal implant devices and methods for promoting fusion between adjacent vertebral bodies, and more particularly to expandable fusion devices that can be inserted between adjacent vertebral bodies to facilitate the fusion thereof.


2. Description of the Relevant Art

The human spine is a complex mechanical structure, composed of alternating bony vertebrae and fibrocartilaginous discs that are connected by strong ligaments and supported by musculature, that extends from the skull to the pelvis and provides axial support for the body.


The vertebrae generally comprise a vertebral foramen bounded by the anterior vertebral body and the neural arch. The vertebral body comprises two end plates (i.e., superior and inferior) made of thin cartilage overlying a thin layer of hard cortical bone that attaches to the spongy, cancellous interior bone of the vertebral body. The neural arch consists of two pedicles and two lamina that are united posteriorly. The spinous and transverse processes protrude from the neural arch. The superior and inferior articular facets lie at the root of the transverse processes.


The intervertebral discs primarily serve as a mechanical cushion between adjacent vertebral segments of the spinal column and generally comprise two basic components: the annulus fibrosis and the nucleus pulposus. The annulus fibrosis forms the outer perimeter of the disc and is a tough ring that binds adjacent vertebrae together. The nucleus pulposus fills the interior of the disc and carries load.


The spine as a whole is a highly flexible structure capable of a high degree of curvature and twist in nearly every direction. However, genetic or developmental irregularities, trauma, chronic stress, and degenerative wear can result in spinal pathologies for which surgical intervention may be necessary.


It is common practice to remove a spinal disc in cases of spinal disc deterioration, disease or spinal injury. More particularly, the discs sometimes become diseased or damaged such that the height of the disc is reduced, which causes the annulus to buckle in areas where the laminated plies are loosely bonded. As the overlapping laminated plies of the annulus begin to buckle and separate, circumferential and/or radial annular tears may occur, allowing nucleus material to escape or form a bulge in the annulus. Such disruption to the natural intervertebral separation and the resulting herniation produces pain, which can be alleviated by removal of the disc and restoration of the natural separation distance. In cases of chronic back or leg pain resulting from a degenerated or herniated disc, removal of the disc can become the desired course of treatment.


In some cases it is desired to fuse the adjacent vertebrae together after removal of the disc. Such a procedure is sometimes referred to as “intervertebral fusion” or “interbody fusion”.


Many techniques and instruments have been devised to perform intervertebral fusion. There is common agreement that the strongest intervertebral fusion is interbody fusion between the lumbar bodies, which may be augmented by a posterior or facet fusion. In cases of intervertebral fusion, either structural bone, or a rigid interbody fusion “cage” typically filled with morselized bone, is placed centrally within the space where the spinal disc once resided. Multiple bony grafts or cages may be used within that space. Furthermore, multiple surgical approaches may be utilized, including anterior, posterior, or lateral surgical approaches.


Such practices are characterized by certain disadvantages, including the need to distract the disc space in order to implant the fusion device and thereby restore the diseased disc space to its normal or healthy height. However, it can be difficult to distract the adjacent vertebral bodies sufficiently to easily insert the fusion device between adjacent vertebral bodies. As a result, it is often necessary to drive the fusion device into the space between the vertebral bodies using impaction with a mallet and the application of significant force. The use of such impaction and force increases the risk of damage to local soft tissue such as blood vessels and the surrounding nerves, and can lead to suboptimal placement and/or failure of the insertion instrumentation. Furthermore, the use of such impaction and force can damage or compromise the vertebral endplates, resulting in eventual failure and subsidence of the fusion device into the vertebral bodies and hence loss of disc height.


Therefore, there is a need for a fusion device that can be placed between adjacent vertebral bodies at minimal height and, thereafter, be variably adjusted with minimal force application to the preferred height for an individual patient. Furthermore, it is desirable that the expandable fusion device be maintained in a closed (i.e., unexpanded) position during insertion and handling, and that it be rigidly attachable to a holder so as to facilitate maximum control by the surgeon during insertion and deployment.


SUMMARY

Accordingly, there is now provided an expandable fusion device that can be placed between adjacent vertebral bodies at minimal height and, thereafter, be variably adjusted with minimal force application to the preferred height for an individual patient. In one embodiment, an expandable PLIF (Posterior Lumbar Interbody Fusion) device or an expandable TLIF (Transforaminal Lumbar Interbody Fusion) device, is disclosed. The expandable fusion device generally includes: a cage, superior and lower bodys, and an expansion mechanism with opposing proximal and second expansion members. The application of torque to the expansion mechanism in one direction causes the proximal and second expansion members to separate, whereby to move the superior and lower bodies away from one another and hence increase the height of expandable fusion device 5. The application of torque to the expansion mechanism in the opposite direction causes the proximal and second expansion members to approach one another, whereby to move the superior and lower bodys toward one another and hence decrease the height of the expandable fusion device.


Further embodiments may include: (i) angled or lordotic superior and lower bodys to match the angle of the disc space; (ii) mismatched proximal and second expansion members, such that the anterior portion of the expandable fusion device opens more than the posterior portion of the expandable fusion device, thereby resulting in a fusion device that increases in both height and lordosis; (iii) dual or multiple expansion mechanisms for anterior spinal approaches; (iv) a curved or flexible holder for the expandable fusion device for oblique access approaches; and (v) additional angled components (i.e., intermediate the aforementioned proximal and second expansion members) for longer expandable fusion devices.


In some embodiments, system and/or method may include an intervertebral implant for a human spine including an upper body, a lower body, first and second expansion members, and an expansion mechanism. The upper body may include an inferior surface and a superior surface. The superior surface of the upper body may function to engage a first vertebra of the human spine. The lower body may include a superior surface and an inferior surface. The inferior surface of the lower body may function to engage a second vertebra of the human spine. The first expansion member may include at least a first angled portion. The first angled portion may be positionable, during use, between the inferior surface of the upper body and the superior surface of the lower body. At least the first angled portion may be oriented towards a first end of the intervertebral implant. The second expansion member may include at least a second angled portion positionable, during use, between the inferior surface of the upper body and the superior surface of the lower body. At least the second angled portion may be oriented towards a second end of the intervertebral implant. At least the second angled portion may be oriented in an opposing direction relative to at least the first angled portion. An expansion mechanism may convey, during use, the first and second angled portions in opposing directions increasing a separation distance between the upper body and the lower body. The first and/or second angled portion may include a wedge-shaped portion.


In some embodiments, the expansion mechanism may include a threaded elongated member. The threaded elongated member may include a proximally threaded portion. The first expansion member may include a threaded opening which the threaded portion of the elongated member engages, during use.


In some embodiments, a distal end of the elongated member engages, during use, a proximal end of the second expansion member. The distal end may engage a recess in the second expansion member and rotates freely within it.


In some embodiments, the expansion mechanism may include a first elongated member and a second elongated member. The first elongated member may include a proximally threaded portion. The first expansion member may include a threaded opening which the threaded portion of the first elongated member engages, during use. The second elongated member may be positionable, during use, in an opening in the second expansion member. A distal end of the first elongated member may engage, during use, a proximal end of the second elongated member. In some embodiments, a distal end of the first elongated member may engage, during use, a proximal end of the second elongated member such that the distal end of the first elongated member is positioned in the opening in the second expansion member.


In some embodiments, the expansion member may include a locking member. The locking member may be positionable in the second expansion member such that the distal end of the first elongated member is inhibited, during use, from removal from the opening in the second expansion member.


In some embodiments, the intervertebral implant may include a cage. The cage may form a perimeter around the intervertebral implant in which at least portions of the upper body, the lower body, the first expansion member, the second expansion member, and the expansion mechanism are positioned, during use, in the cage. The cage may include one or more openings along the perimeter to allow graft material to be positioned during use.


In some embodiments, a lateral cross section of a perimeter of the intervertebral implant may include a curved shape such that at least a first portion of the perimeter is substantially convex and at least a second portion of the perimeter is substantially concave, wherein the second portion is substantially opposite the first portion.


In some embodiments, the upper body and/or the lower body may include an opening wherein graft material is positionable during use. The upper body and/or the lower body may include an opening which increases in size as the first and second angled portions are conveyed in opposing directions.


In some embodiments, the superior surface of the upper body and/or the inferior surface of the lower body may include protrusions (e.g., teeth). The protrusions may promote, during use, retention of the implant between the first vertebra and the second vertebra after insertion.





BRIEF DESCRIPTION OF THE DRAWINGS

Advantages of the present invention may become apparent to those skilled in the art with the benefit of the following detailed description of the preferred embodiments and upon reference to the accompanying drawings.



FIG. 1 depicts a schematic side view showing an expandable fusion device formed in accordance with the present invention, with the expandable fusion device being disposed between adjacent vertebral bodies.



FIG. 2 depicts a schematic exploded view of an expandable fusion device.



FIG. 3 depicts a schematic front perspective view of an expandable fusion device, with the expandable fusion device being shown in an unexpanded position.



FIG. 4 depicts a schematic front perspective view of an expandable fusion device, with the expandable fusion device being shown in an expanded position.



FIG. 5 depicts a schematic rear perspective view of an expandable fusion device, with the expandable fusion device being shown in an unexpanded position.



FIG. 6 depicts a schematic rear perspective view of an expandable fusion device, with the expandable fusion device being shown in an expanded position.



FIG. 7 is a schematic side view of an expandable fusion device, with the expandable fusion device being shown in an unexpanded position.



FIG. 8 depicts a schematic side view of an expandable fusion device, with the expandable fusion device being shown in an expanded position.



FIG. 9 depicts a schematic top view of an expandable fusion device.



FIG. 10 depicts a schematic side cross-sectional view of an expandable fusion device, with the expandable fusion device being shown in an unexpanded position.



FIG. 11 depicts a schematic side cross-sectional view of an expandable fusion device, with the expandable fusion device being shown in an expanded position.



FIG. 12 depicts a schematic perspective cross-sectional view of an expandable fusion device, with the expandable fusion device being shown in an unexpanded condition.



FIG. 13 depicts a schematic perspective view of a lower body.



FIG. 14 depicts a schematic perspective cross-sectional view of a lower body.



FIG. 15 depicts a schematic perspective cross-sectional view of an upper body.



FIG. 16 depicts a schematic right side perspective view of the proximal and second expansion members.



FIG. 17 depicts a schematic left side perspective view of the proximal and second expansion members.



FIG. 18 depicts a schematic view showing insertion instruments for use with an expandable fusion device.



FIG. 19 depicts a schematic transparent side view of an expandable fusion device.



FIG. 20 depicts a schematic exploded view of an expandable fusion device.



FIG. 21 depicts a schematic cross-sectional view of a curved expandable fusion device in an unexpanded state.



FIG. 22 depicts a schematic cross-sectional view of a curved expandable fusion device in an expanded state.



FIG. 23 depicts a schematic view of a curved expandable fusion device as the device is being inserted between two adjacent vertebrae.



FIG. 24 depicts a schematic view showing insertion instruments for use with an expandable fusion device.



FIG. 25 depicts a schematic view showing a distal end of an insertion instrument for use with an expandable fusion device.



FIG. 26 depicts a schematic view showing a proximal end of an insertion instrument for use with an expandable fusion device.



FIG. 27 depicts a schematic view of a disposable expandable fusion implant insertion device.



FIG. 28 depicts a schematic transparent view of a disposable expandable fusion implant insertion device.



FIG. 29 depicts a schematic perspective view of an expandable fusion implant in an expanded state wherein an upper body portion of the implant is depicted as transparent.



FIG. 30 depicts a schematic perspective view of an expandable fusion implant in an expanded state wherein an upper body portion of the implant is depicted as transparent.



FIG. 31 depicts a schematic perspective view of an expandable fusion implant in a contracted state.



FIG. 32 depicts a schematic perspective view of an expandable fusion implant in a contracted state coupled to an insertion instrument with portions of the insertion instruments depicted as transparent. An upper body of the implant is not depicted and a second expandable member is depicted as transparent.



FIG. 33 depicts a schematic view of an insertion instrument with an expandable fusion device.



FIG. 34 depicts a schematic view of a distal end of an insertion instrument with an expandable fusion device.



FIG. 35 depicts a schematic view of a distal end of an insertion instrument with an expandable fusion device with a portion of the insertion instrument removed for clarity.



FIG. 36 depicts a schematic view of a distal end of an insertion instrument with an expandable fusion device with a portion of the insertion instrument removed for clarity.



FIG. 37 depicts a schematic perspective view of an expandable fusion implant in a contracted state. At least an upper body and a cage of the implant is not depicted.





While the invention is susceptible to various modifications and alternative forms, specific embodiments thereof are shown by way of example in the drawings and may herein be described in detail. The drawings may not be to scale. It should be understood, however, that the drawings and detailed description thereto are not intended to limit the invention to the particular form disclosed, but on the contrary, the intention is to cover all modifications, equivalents and alternatives falling within the spirit and scope of the present invention as defined by the appended claims.


The headings used herein are for organizational purposes only and are not meant to be used to limit the scope of the description. As used throughout this application, the word “may” is used in a permissive sense (i.e., meaning having the potential to), rather than the mandatory sense (i.e., meaning must). The words “include,” “including,” and “includes” indicate open-ended relationships and therefore mean including, but not limited to. Similarly, the words “have,” “having,” and “has” also indicated open-ended relationships, and thus mean having, but not limited to. The terms “first,” “second,” “third,” and so forth as used herein are used as labels for nouns that they precede, and do not imply any type of ordering (e.g., spatial, temporal, logical, etc.) unless such an ordering is otherwise explicitly indicated. For example, a “third die electrically connected to the module substrate” does not preclude scenarios in which a “fourth die electrically connected to the module substrate” is connected prior to the third die, unless otherwise specified. Similarly, a “second” feature does not require that a “first” feature be implemented prior to the “second” feature, unless otherwise specified.


Various components may be described as “configured to” perform a task or tasks. In such contexts, “configured to” is a broad recitation generally meaning “having structure that” performs the task or tasks during operation. As such, the component can be configured to perform the task even when the component is not currently performing that task (e.g., a set of electrical conductors may be configured to electrically connect a module to another module, even when the two modules are not connected). In some contexts, “configured to” may be a broad recitation of structure generally meaning “having circuitry that” performs the task or tasks during operation. As such, the component can be configured to perform the task even when the component is not currently on. In general, the circuitry that forms the structure corresponding to “configured to” may include hardware circuits.


Various components may be described as performing a task or tasks, for convenience in the description. Such descriptions should be interpreted as including the phrase “configured to.” Reciting a component that is configured to perform one or more tasks is expressly intended not to invoke 35 U.S.C. § 112, paragraph six, interpretation for that component.


The scope of the present disclosure includes any feature or combination of features disclosed herein (either explicitly or implicitly), or any generalization thereof, whether or not it mitigates any or all of the problems addressed herein. Accordingly, new claims may be formulated during prosecution of this application (or an application claiming priority thereto) to any such combination of features. In particular, with reference to the appended claims, features from dependent claims may be combined with those of the independent claims and features from respective independent claims may be combined in any appropriate manner and not merely in the specific combinations enumerated in the appended claims.


It is to be understood the present invention is not limited to particular devices or biological systems, which may, of course, vary. It is also to be understood that the terminology used herein is for the purpose of describing particular embodiments only, and is not intended to be limiting. As used in this specification and the appended claims, the singular forms “a”, “an”, and “the” include singular and plural referents unless the content clearly dictates otherwise. Thus, for example, reference to “a linker” includes one or more linkers.


DETAILED DESCRIPTION

Definitions


Unless defined otherwise, all technical and scientific terms used herein have the same meaning as commonly understood by one of ordinary skill in the art.


The term “connected” as used herein generally refers to pieces which may be joined or linked together.


The term “coupled” as used herein generally refers to pieces which may be used operatively with each other, or joined or linked together, with or without one or more intervening members.


The term “directly” as used herein generally refers to one structure in physical contact with another structure, or, when used in reference to a procedure, means that one process effects another process or structure without the involvement of an intermediate step or component.


Looking first at FIG. 1, there is shown an intervertebral implant 5 (e.g., expandable fusion device) formed in accordance with the present invention, with the intervertebral implant 5 being shown disposed between a superior vertebral body 10 and an inferior vertebral body 15. As will hereinafter be discussed in further detail, intervertebral implant 5 may be inserted between superior vertebral body 10 and inferior vertebral body 15 while the intervertebral implant is in a contracted condition (e.g., as depicted in FIGS. 3 and 5), and thereafter expanded (e.g., as depicted in FIGS. 4 and 6) as necessary so as to span and engage the endplate 20 of superior vertebral body 10 and the endplate 25 of inferior vertebral body 15, whereby to support superior vertebral body 10 and inferior vertebral body 15 relative to one another.


In some embodiments, (e.g., as depicted in FIG. 2) intervertebral implant 5 (e.g., as depicted in FIG. 2) generally includes a cage 30, an upper body 35, a lower body 40, an expansion mechanism 45, a first expansion member 50 (e.g., positioned proximally) and a second expansion member 55 (e.g., positioned distally). As will hereinafter be discussed, the application of torque to expansion mechanism 45 in one direction causes first expansion member 50 and second expansion member 55 to separate, whereby to move upper body 35 and lower body 40 away from one another and hence increase the height of intervertebral implant 5. The application of torque to expansion mechanism 45 in the opposite direction causes first expansion member 50 and second expansion member 55 to draw towards one another, whereby to move upper body 35 and lower body 40 toward one another and hence decrease the height of intervertebral implant 5. In some embodiments, the mechanism may be reversed with, for example, the expansion members moving towards one another during expansion (although the opening for biological material might be reduced in such an embodiment).


Designs which may be similar but with for example expansion members conveying in the same direction may have a mechanical disadvantage relative to the embodiments described herein wherein the expansion members are conveyed in opposing directions. Expansion members which are conveyed in opposing directions may require half of the input torque to move as opposed to expansion members which are conveyed in the same direction.


In some embodiments, a cage 30 includes a generally rectangular structure 60 having a hollow interior 65, a distal opening 70 and a proximal opening 75. Two seats 80 are formed in the opposing side surfaces of cage 30.


Upper body 35 generally includes a block 85 having an inferior recess 90, and a textured superior surface 95, and a pair of inclined camming surfaces 100, 105. Camming surfaces 100, 105 of upper body 35 may be inclined in opposite directions (e.g., as depicted in FIG. 15).


Lower body 40 generally includes a block 110 having a superior recess 115, a textured inferior surface 120 and a pair of inclined camming surfaces 125, 130. Camming surfaces 125, 130 of lower body 40 may be inclined in opposite directions (e.g., as depicted in FIGS. 13-14).


In some embodiments, the camming surface 100 of upper body 35 and the camming surfaces 130 of lower body 40 extend parallel to one another, and the camming surfaces 105 of upper body 35 and the camming surface 125 of lower body 40 extend parallel to one another.


Expansion mechanism 45 generally includes an elongated shaft 135 having an annular shoulder 140 formed intermediate its length. A groove 145 is formed distal to annular shoulder 140. Screw threads 147 are formed on the outer surface of elongated shaft 135 proximal to annular shoulder 140. A noncircular bore 150 opens on the proximal end of expansion mechanism 45 and extends distally thereof.


Superior and/or inferior surfaces of the implant (e.g., textured superior surface 95 and textured inferior surface 120) may include various features to facilitate engagement of the surfaces with endplates of adjacent vertebrae. In some embodiments, the implant may include a plurality of surface deformations positioned on the inferior surface and/or the superior surface. Surface deformations may include protrusions. For example (e.g., depicted in FIG. 7) superior surface of the implant 5 may include protrusions (e.g., teeth) 154 extending there from. During use, teeth 154 may extend/penetrate into adjacent boney structure of the upper and lower adjacent vertebrae. Such penetration may help to fix a position of the implant 5 relative to the vertebrae. Fixing or otherwise stabilizing the implant may reduce the likelihood of implant 5 being expelled from within the intervertebral space, and may promote bone attachment to and through implant 5. In some embodiments, various spray coatings may be applied to one or more exterior surfaces to, for example, enhance fixation with adjacent bone surfaces.


In some embodiments, protrusions 154 may include directional teeth that facilitate movement of the members in a first direction, but inhibit movement of the members in a second opposing direction. For example, in the illustrated embodiment, teeth 154 include a ramped leading surface 154a and a substantially vertical trailing edge 154b (e.g., depicted in FIGS. 7-8). Thus, forward advancement of the members may be facilitated as boney structure of the vertebrae slides over ramped leading surface 154a of teeth 154 and backward advancement may be inhibited by substantially vertical trailing edge 154b hooking into or otherwise engaging the boney structure of the vertebrae.


In some embodiments, one or more portions of the implant may include one or more markers. Markers may be used to assess a position of one or more portions of the implant during implantation in a subject. A portion of the implant may include none, one or multiple markers. Markers may provide radiographic opacity. Markers may be biocompatible. Markers may be of any size or shape. In some embodiments, a system may have multiple markers with different shapes in order to more easily identify different portions or directions of the system and/or an orientation of one or more portions of the implant. In some embodiments, one or more markers may be formed from gold or tantalum.


In some embodiments, the implant 5 may include an opening 152a extending through the implant (e.g., depicted in FIGS. 9-12). The opening may hold biological material during use. In some embodiments, opening 152a may be filled with a substance/material to facilitate bone growth/fusion. Once implant 5 is implanted, the opening may facilitate a column of bone growth between the adjacent vertebrae through the opening 152a. In some embodiments, an opening (e.g., opening 152a) may function as a graft window containing bone chips and/or materials which facilitate tissue (e.g., bone) growth. The opening may increase in size as the first and second expansion members move away from each other as the implant is deployed.


In some embodiments, implant 5 may include one or more second openings 152b (e.g., depicted in FIG. 20). The second openings may be positioned on either side of cage 30. The openings may facilitate insertion of biological material. After positioning an implant during use opening 152a may be blocked by the vertebrae and therefore additional openings 152b may facilitate in packing of biological material (e.g., bone graft). The openings may be initially at least partially blocked by the first and second expansion members and/or the upper and lower bodies, as the implant is expanded the second openings may open up.


In some embodiments, implant 5 may include a proximal opening 152c (e.g., depicted in FIG. 29). A proximal opening may allow biological material to be positioned in the interior of the implant after the implant has been positioned. The proximal opening may facilitate insertion of biological material after insertion of the implant. In some embodiments, a proximal opening in the implant may necessitate positioning the expansion mechanism (e.g., elongated members 45a-b as depicted in FIGS. 30-31) off center in order to allow for creating a large enough proximal opening. In some embodiments, the first expansion member 50 may be modified to allow biological material inserted through the proximal opening to pass beyond the first expansion member into the space between the first and the second expansion member 50, 55. The first expansion member may include an opening 156 and/or shaped to create an opening in combination with an interior surface of the cage 30 (e.g., as depicted in FIGS. 32 and 37).


In some embodiments, a distal end 235 of the elongated member (e.g., expansion mechanism 45a) engages, during use, a proximal end of the second expansion member 55. In such an embodiment, the distal end of the elongated member abuts a proximal end of the second expansion member as opposed to extending through an opening in the second expansion member. The distal end may engage a recess 240 in the second expansion member 55 (e.g., as depicted in FIG. 19). A recess may include a shallow opening. The distal end may turn freely in the recess. The recess may assist in centering and/or positioning the distal end of the elongated member 45 such that the distal end is inhibited from misaligning and/or disengaging from the second expansion member. In some embodiments, the implant 5 may include a second elongated member 45b. The second elongated member 45b may be positioned in the second expansion member 55 and opening 70 such that the second elongated member keeps the second expansion member centered.


In some embodiments, the expansion mechanism may include a first elongated member 45a and a second elongated member 45b (e.g., as depicted in FIG. 20). The first elongated member 45a may include a proximally threaded portion 147. The first expansion member 50 may include a threaded opening 180 which the threaded portion of the first elongated member engages, during use. The second elongated member 45b may be positionable, during use, in an opening 210 in the second expansion member 55. A distal end 245 of the first elongated member 45a may engage, during use, a proximal end 250 of the second elongated member 45b. In some embodiments, a distal end of the first elongated member may engage, during use, a proximal end of the second elongated member such that the distal end of the first elongated member is positioned in the opening in the second expansion member. The distal end of the first elongated member may turn freely in the opening in the second expansion member. In some embodiments, the second elongated member may function to keep the second expansion member 55 central in the body of the implant. In some embodiments, the second elongated member may be essentially non-rotating relative to the first elongated member.


The result is that the separation between the expansion members is thus equal to just one pitch of the thread per rotation, or ½ pitch of movement relative to the endplate (upper & lower body) each. As such for a given torque one may provide approximately twice the lifting force as compared to dual expansion members moving in the same direction at 1 pitch per rotation. Embodiments discussed herein would have twice the separation force relative to a turnbuckle thread configured with opposing expansion members (or even with expansion members moving in the same direction) because they separate/collapse at a rate of 2 pitches per rotation and thus have twice the motion relative to the endplates.


In some embodiments, a size of the expansion member (e.g., screw) may be reduced to get the same force at a lower torque because passive rotation within one of the expansion members is more efficient. One may reduce the angle of the ramp or have a single ramp, but you would need considerably more travel to achieve the same height and would run into length limitations. Many embodiments described herein increase rotations not travel.


Forming the expansion mechanism from two elongated members as opposed to a single elongated member has several advantages. For example when retracting upper body 35 and lower body 40 from an engaged position to an unengaged position, torque applied to the expansion mechanism during retraction may lead to failure of the expansion mechanism when the expansion mechanism includes a single elongated member. When the expansion mechanism includes two elongated members, failure of the expansion mechanism when counter (retracting) torque is applied is inhibited.


In some embodiments, one or more of the expansion members may include a locking member 255. The locking member may be positionable in the second expansion member 55 such that the second elongated member is inhibited, during use, from removal from the opening in the second expansion member. The locking member may include a pin. The pin may be positioned in an opening in the second expansion member. In some embodiments, the locking member may engage a recess 260 in the second elongated member. The recess may circumscribe the circumference of the second elongated member such that the second elongated member does not have to be oriented in a particular direction relative to the second elongated member. In some embodiments, the locking member may be used in combination with the single elongated member (e.g., snap ring 215 as depicted in FIG. 2).


In some embodiments, first expansion member 50 includes a generally wedge-shaped body 155 having a superior camming surface 160, an inferior cam surface 165, a pair of superior fingers 170 and a pair of inferior fingers 175 (e.g., as depicted in FIG. 16). Significantly, superior camming surface 160 of first expansion member 50 extends parallel to camming surface 100 of upper body 35, and inferior camming surface 165 of first expansion member 50 extends parallel to camming surface 125 of lower body 40. In lordotic embodiments these surfaces may only be parallel in the open position. They are not parallel when closed. First expansion member 50 may include a threaded bore 180 extending there through. Threaded bore 180 is sized to be threadingly engaged by screw threads 147 on elongated shaft 135.


In some embodiments, second expansion member 55 includes a generally wedge-shaped body 185 having a superior camming surface 190, an inferior camming surface 195, a pair of superior fingers 200 and a pair of inferior fingers 205 (e.g., as depicted in FIGS. 16-17). Significantly, superior camming surface 190 of second expansion member 55 extends parallel to camming surface 105 of upper body 35, and inferior camming surface 195 of second expansion member 55 extends parallel to camming surface 130 of lower body 40. In lordotic embodiments these surfaces may only be parallel in the open position. They are not parallel when closed. Second expansion member 55 may include a smooth bore 210 extending there through. Smooth bore 210 may be sized to receive the portion of expansion mechanism 45 distal to annular shoulder 140.


Camming surfaces of the upper/lower bodies and the expansion members may be substantially flat as depicted in some of the attached FIGS. In some embodiments, at least some of the camming surfaces may be curved. Complementary camming surfaces may be complementarily shaped. Complementary camming surfaces may not be complementarily shaped.


In some embodiments, intervertebral implant 5 may be assembled so that expansion mechanism 45 extends through proximal opening 75 in cage 30 (without engaging proximal opening 75 in cage 30), and first expansion member 50 and second expansion member 55 are disposed on shaft 135 of expansion mechanism 45 within the hollow interior 65 of cage 30. More particularly, first expansion member 50 may be mounted on elongated shaft 135 of expansion mechanism 45 so that screw threads 147 are threadingly received in threaded bore 180 of first expansion member 50, and second expansion member 55 is mounted on elongated shaft 135 of expansion mechanism 45 so that second expansion member 55 is captured on elongated shaft 135 between annular shoulder 140 and a snap ring 215 secured in groove 145. At the same time, upper body 35 and lower body 40 may extend into hollow interior 65 of exterior body 30 so that (i) camming surface 100 of upper body 35 rides on camming surface 160 of first expansion member 50, (ii) camming surface 105 of upper body 35 rides on camming surface 190 of second expansion member 55, (iii) camming surface 125 of lower body 40 rides on camming surface 165 of first expansion member 50, and (iv) camming surface 130 of lower body 40 rides on camming surface 195 of second expansion member 55.


It will be appreciated that, as a result of the foregoing construction, the application of torque to expansion mechanism 45 in one direction (e.g., in a noncircular bore 150 in expansion mechanism 45) causes first expansion member 50 and second expansion member 55 to separate, whereby to move upper body 35 and lower body 40 apart and hence increase the height of intervertebral implant 5. It will be appreciated that, as a result of the foregoing construction, the application of torque to expansion mechanism 45 in the opposite direction causes first expansion member 50 and second expansion member 55 to draw together, whereby to move upper body 35 and lower body 40 together and hence decrease the height of intervertebral implant 5.


In some embodiments, the intervertebral implant 5 may include a curved cross-section. Straight designs are more commonly associated with PLIF (direct posterior placement in pairs), or lateral approaches (one longer device placed from the side of the spine). FIG. 21 is a schematic cross-sectional view of a curved expandable fusion device in an unexpanded state with a curved cross-section. FIG. 22 is a schematic cross-sectional view of a curved expandable fusion device in an expanded state with a curved cross-section. In some embodiments, portions of the implant may be curved or angled in order to accommodate the curved cross-section of the perimeter. In some embodiments, expansion members and the expansion mechanism may not require adjustments to assimilate into an implant with a curved perimeter. The distal end 235 of the expansion mechanism 45a may engage a recess 240 in the second expansion member 55 as discussed herein and in the case of a curved implant the recess may adjusted to compensate for the varying angle of engagement of the distal end with the recess during expansion. In some embodiments, the distal end of the expansion mechanism may be curved in order to accommodate a curved perimeter.


The reason TLIF cages are typically curved is that the surgical technique would be to place them from a posterior-lateral approach, as much as 45 degrees off the midline, where they are tamped and rotated to the front of the vertebral body. A curved implant may facilitate insertion of the implant between adjacent vertebrae. An implant with a curved perimeter may better mimic and accommodate the existing perimeter of the average vertebra. FIG. 23 depicts a schematic view of a curved expandable fusion device 5 as the device is being inserted between two adjacent vertebrae. In some embodiments, the implant inserter may be curved. The expansion mechanism may have a flexible shaft to allow rotation within the curve. The relative advantages of an expandable feature may in fact be greater because it would significantly reduce the impaction required to maneuver the device into final position at the front of the spine.


In some embodiments, an implant system may include an implant insertion device 300. FIG. 18 shows a handle 215, a holder 220 and an engaging member 225 which may be used to manipulate and deploy intervertebral implant 5. More particularly, handle 215 includes two extensions 230 for positioning in seats 80 (e.g., as depicted in FIGS. 3-6) of intervertebral implant 5. Holder 220 may be positionable in handle 215 and threadingly engages the distal end of expansion mechanism 45, whereby to releasably secure intervertebral implant 5 to handle 215. Engaging member 225 may be positionable in holder 220 and into bore 150 in expansion mechanism 45, whereby to permit the user to turn expansion mechanism 45 and hence adjust the height of the intervertebral implant 5. Engaging member 225 may include engaging head 226 which engages bore 150. Engaging head 226 may include a complementary shape to bore 150 such that as the head turns the expansion member 45 turns.


In some embodiments, an implant system may include an implant insertion device 300. FIGS. 24-26 depict a schematic view showing insertion instruments 300 for use with an expandable fusion device. FIGS. 24-26 depict a handle 215, a holder 220 and an engaging member 225 which may be used to manipulate and deploy intervertebral implant 5. More particularly, handle 215 includes two extensions 230 for positioning in seats 80 (e.g., as depicted in FIGS. 24-25) of intervertebral implant 5. Engaging member 225 may be positionable in holder 220 and into bore 150 in expansion mechanism 45, whereby to permit the user to turn expansion mechanism 45 and hence adjust the height of the intervertebral implant 5. Engaging member 225 may include engaging head 226 which engages bore 150. Engaging head 226 may include a complementary shape to bore 150 such that as the head turns the expansion member 45 turns. In some embodiments, the insertion instrument 300 may include a grip 280 coupled to engaging member 225. In some embodiments, engaging member 225 may include a threaded proximal portion 285. The threaded portion 285 may function to assist in controlling longitudinal movement of the engaging member and therefore expansion of the implant.


In some embodiments, an insertion device may be disposable. FIGS. 27-28 depict a schematic view of a disposable expandable fusion implant insertion device 300. A disposable insertion device may be packaged with an implant. The insertion device may allow bone graft to be packed after insertion. The “disposable” option may allow the holder to act as an internal funnel which would make cleaning difficult, but a “durable version” remains an option. In some embodiments, engaging member 225 may be used to pack biological material into the implant through holder 220. In some embodiments, a separate packing instrument (not depicted) may be used to insert biological material.



FIGS. 32-36 depict a schematic view showing insertion instruments 300 for use with an expandable fusion device. FIGS. 32-36 depict a handle 215, a holder 220 and an engaging member 225 which may be used to manipulate and deploy intervertebral implant 5. More particularly, handle 215 includes two extensions 230 for positioning in seats 80 (e.g., as depicted in FIGS. 24-25) of intervertebral implant 5. In some embodiments, the extensions may be spring loaded (e.g., using springs, forming at least a portion of the extensions from an at least slightly flexible material, etc.) such that they are biased to be positioned such that they apply pressure to the seats of the implant during use. In some embodiments, a mechanism may be employed to engage/release the extensions from the implant.


The insertion instrument may include at least two holders 220 which couple to opposing sides (e.g., the inferior and superior surfaces of the implant) of the implant during use. In some embodiments, the holders may be spring loaded (e.g., using springs, forming at least a portion of the holders from an at least slightly flexible material, etc.) such that they are biased to be positioned such that they apply pressure to the surfaces of the implant during use. In some embodiments, a mechanism may be employed to engage/release the holders from the implant. The holders may include a curved edge or lip which curve towards one another. The curved edge may engage an appropriately shaped portion of the proximal end of the implant.


Engaging member 225 may be positionable in handle 215 and into bore 150 in expansion mechanism 45, whereby to permit the user to turn expansion mechanism 45 and hence adjust the height of the intervertebral implant 5. Engaging member 225 may include engaging head 226 which engages bore 150. Engaging head 226 may include a complementary shape to bore 150 such that as the head turns the expansion member 45 turns. In some embodiments, the insertion instrument 300 may include a grip 280 coupled to engaging member 225.


In this patent, certain U.S. patents, U.S. patent applications, and other materials (e.g., articles) have been incorporated by reference. The text of such U.S. patents, U.S. patent applications, and other materials is, however, only incorporated by reference to the extent that no conflict exists between such text and the other statements and drawings set forth herein. In the event of such conflict, then any such conflicting text in such incorporated by reference U.S. patents, U.S. patent applications, and other materials is specifically not incorporated by reference in this patent.


Further modifications and alternative embodiments of various aspects of the invention will be apparent to those skilled in the art in view of this description. Accordingly, this description is to be construed as illustrative only and is for the purpose of teaching those skilled in the art the general manner of carrying out the invention. It is to be understood that the forms of the invention shown and described herein are to be taken as the presently preferred embodiments. Elements and materials may be substituted for those illustrated and described herein, parts and processes may be reversed, and certain features of the invention may be utilized independently, all as would be apparent to one skilled in the art after having the benefit of this description of the invention. Changes may be made in the elements described herein without departing from the spirit and scope of the invention as described in the following claims.

Claims
  • 1. A method for increasing the spacing between two adjacent vertebral bodies, the method comprising: removing at least a portion of a disc between two vertebrae of the human spine to create a space between the two vertebrae;positioning an intervertebral implant in the space between the two vertebrae, wherein the intervertebral implant comprises: a cage comprising a first end portion, a second end portion, a longitudinal axis extending between the first end portion and the second end portion, an upper portion and a lower portion;an upper body movably mounted to the cage, the upper body comprising an inferior surface and a superior surface;a lower body movably mounted to the cage, the lower body comprising a superior surface and an inferior surface;a first expansion member comprising at least a first inclined portion, wherein at least the first inclined portion is oriented towards the first end portion of the cage;a second expansion member comprising at least a second inclined portion, wherein at least the second inclined portion is oriented towards the second end portion of the cage; andan expansion mechanism movably mounted to the cage, wherein the expansion mechanism comprises a threaded portion for threadingly engaging a threaded portion of the first expansion member, and further wherein the second expansion member is non-threadingly coupled to the expansion mechanism, such that when the expansion mechanism is rotated, the expansion mechanism moves relative to the cage, the first expansion member is moved relative to the cage and relative to the expansion mechanism, and the second expansion member is moved relative to the cage in the opposing direction, so as to increase a separation distance between the upper body and the lower body; androtating the expansion mechanism so as to move the first and second expansion members in opposing directions so as to increase a separation distance between the upper body and the lower body.
  • 2. The method of claim 1; further comprising engaging a first vertebra of the human spine using the superior surface of the upper body.
  • 3. The method of claim 2, wherein the superior surface of the upper body comprises teeth for engaging the first vertebra.
  • 4. The method of claim 1, further comprising engaging a second vertebra of the human spine using the inferior surface of the lower body.
  • 5. The method of claim 4, wherein the inferior surface of the lower body comprises teeth for engaging the second vertebra.
  • 6. The method of claim 1, wherein, when the expansion mechanism is rotated, the first inclined portion of the first expansion member moves towards the first end portion of the cage and the second inclined portion of the second expansion member moves towards the second end portion of the cage.
  • 7. The method of claim 1, wherein, when the expansion mechanism is rotated, one of the first expansion member and the second expansion member moves a further distance relative to the cage than the other of the first expansion member and the second expansion member.
  • 8. The method of claim 1, wherein, before rotation of the expansion mechanism, the superior surface of the upper body and the inferior surface of the lower body are parallel to the longitudinal axis of the cage.
  • 9. The method of claim 1, wherein, before rotation of the expansion mechanism, the superior surface of the upper body and the inferior surface of the lower body are both inclined relative to the longitudinal axis of the cage.
  • 10. The method of claim 1, wherein, after rotation of the expansion mechanism, the superior surface of the upper body and the inferior surface of the lower body are parallel to the longitudinal axis of the cage.
  • 11. The method of claim 1, wherein; after rotation of the expansion mechanism, the superior surface of the upper body and the inferior surface of the lower body are both inclined relative to the longitudinal axis of the cage.
  • 12. The method of claim 1, wherein the first inclined portion of the first expansion member comprises a flat surface.
  • 13. The method of claim 1, wherein the second inclined portion of the second expansion member comprises a flat surface.
  • 14. The method of claim 1, wherein the first inclined portion of the first expansion member comprises a curved surface.
  • 15. The method of claim 1, wherein the second inclined portion of the second expansion member comprises a curved surface.
  • 16. The method of claim 1 wherein the first inclined portion of the first expansion member comprises a first geometry, the second inclined portion of the second expansion member comprises a second geometry, and further wherein the first geometry is different from the second geometry.
  • 17. The method of claim 1, wherein the cage forms a perimeter for the intervertebral implant, and further wherein at least portions of the upper body, the lower body, the first expansion member, the second expansion member, and the expansion mechanism are positioned within the perimeter.
  • 18. The method of claim 17, wherein the cage comprises a curved shape such that a first portion of the perimeter is substantially convex and a second portion of the perimeter is substantially concave, wherein the second portion is substantially opposite the first portion.
  • 19. The method of claim 17, wherein the cage comprises one or more openings along the perimeter to allow graft material to be positioned during use.
  • 20. The method of claim 1, wherein at least one of the upper body and the lower body comprises an opening within which graft material is positionable during use.
  • 21. The method of claim 1, wherein the upper body and the lower body define an opening therebetween, and further wherein this opening increases in size as the first and second inclined portions of the first and second expansion members, respectively, are moved.
REFERENCE TO PENDING PRIOR PATENT APPLICATIONS

This patent application is a continuation of pending prior U.S. patent application Ser. No. 15/351,943, filed Nov. 15, 2016 by Flexuspine, Inc. for EXPANDABLE FUSION DEVICE FOR POSITIONING BETWEEN ADJACENT VERTEBRAL BODIES, which in turn is a continuation of prior U.S. patent application Ser. No. 14/185,561, filed Feb. 20, 2014 by Erik Wagner et al. for EXPANDABLE FUSION DEVICE FOR POSITIONING BETWEEN ADJACENT VERTEBRAL BODIES, which claims benefit of prior U.S. Provisional Patent Application Ser. No. 61/766,982, filed Feb. 20, 2013 by Erik Wagner et al. for EXPANDABLE FUSION DEVICE FOR POSITIONING BETWEEN ADJACENT VERTEBRAL BODIES. The three (3) above-identified patent applications are hereby incorporated herein by reference.

US Referenced Citations (647)
Number Name Date Kind
3848601 Ma et al. Nov 1974 A
3867728 Substad et al. Feb 1975 A
4309777 Patil Jan 1982 A
4349921 Kuntz Sep 1982 A
4611581 Steffee Sep 1986 A
4657550 Daher Apr 1987 A
4696290 Steffee Sep 1987 A
4743260 Burton May 1988 A
4759766 Buettner-Janz et al. Jul 1988 A
4759769 Hedman et al. Jul 1988 A
4763644 Webb Aug 1988 A
4772287 Ray et al. Sep 1988 A
4854311 Steffee Aug 1989 A
4863476 Shepperd Sep 1989 A
4863477 Monson Sep 1989 A
4907577 Wu Mar 1990 A
4911718 Lee et al. Mar 1990 A
4932975 Main et al. Jun 1990 A
4946378 Hirayama et al. Aug 1990 A
4946458 Harms et al. Aug 1990 A
5042982 Harms et al. Aug 1991 A
5047055 Bao et al. Sep 1991 A
5059194 Michelson Oct 1991 A
5071437 Steffee Dec 1991 A
5092867 Harms et al. Mar 1992 A
5108438 Stone Apr 1992 A
5123926 Pisharodi Jun 1992 A
5171278 Pisharodi Dec 1992 A
5171281 Parsons et al. Dec 1992 A
5180393 Commarmond Jan 1993 A
5192326 Bao et al. Mar 1993 A
5196013 Harms et al. Mar 1993 A
5207678 Harms et al. May 1993 A
5217497 Mehdian Jun 1993 A
5246458 Graham Sep 1993 A
5258031 Salib et al. Nov 1993 A
5261909 Sutterlin et al. Nov 1993 A
5306307 Senter et al. Apr 1994 A
5306309 Wagner et al. Apr 1994 A
5314477 Marnay May 1994 A
5320644 Baumgartner Jun 1994 A
5336223 Rogers Aug 1994 A
5370697 Baumgartner Dec 1994 A
5375823 Navas Dec 1994 A
5397364 Kozak et al. Mar 1995 A
5401269 Buettner-Janz et al. Mar 1995 A
5403315 Ashman Apr 1995 A
5415661 Holmes May 1995 A
5458643 Heggeness et al. May 1995 A
5423816 Lin Jun 1995 A
5425773 Boyd et al. Jun 1995 A
5443467 Biedermann et al. Aug 1995 A
5458642 Beer et al. Oct 1995 A
5480401 Navas Jan 1996 A
5496321 Puno et al. Mar 1996 A
5498263 DiNello et al. Mar 1996 A
5507816 Bullivant Apr 1996 A
5514132 Csernatony et al. May 1996 A
5514180 Heggeness et al. May 1996 A
5522899 Michelson Jun 1996 A
5527314 Brumfield et al. Jun 1996 A
5534028 Bao et al. Jul 1996 A
5534029 Shima Jul 1996 A
5534030 Navarro et al. Jul 1996 A
5540688 Navas Jul 1996 A
5545165 Biedermann et al. Aug 1996 A
5556431 Buettner-Janz Sep 1996 A
5562663 Wisnewski et al. Oct 1996 A
5562737 Graf Oct 1996 A
5562738 Boyd et al. Oct 1996 A
5571109 Bertagnoli Nov 1996 A
5609635 Michelson Mar 1997 A
5624442 Mellinger et al. Apr 1997 A
5645599 Samani Jul 1997 A
5653763 Errico et al. Aug 1997 A
5665122 Kambin Sep 1997 A
5672175 Martin Sep 1997 A
5672176 Biedermann et al. Sep 1997 A
5674294 Bainville et al. Oct 1997 A
5674296 Bryan et al. Oct 1997 A
5676701 Yuan et al. Oct 1997 A
5676702 Ratron Oct 1997 A
5683391 Boyd Nov 1997 A
5683464 Wagner et al. Nov 1997 A
5683465 Shinn et al. Nov 1997 A
5702450 Bisserie Dec 1997 A
5725527 Biedermann et al. Mar 1998 A
5733284 Martin Mar 1998 A
5741253 Michelson Apr 1998 A
5755797 Baumgartner May 1998 A
5772661 Michelson Jun 1998 A
5776199 Michelson Jul 1998 A
5782832 Larsen et al. Jul 1998 A
5785647 Tompkins et al. Jul 1998 A
5797909 Michelson Aug 1998 A
5800549 Bao et al. Sep 1998 A
5800550 Sertich Sep 1998 A
5810819 Errico et al. Sep 1998 A
5824093 Ray et al. Oct 1998 A
5824094 Serhan et al. Oct 1998 A
5827328 Buttermann Oct 1998 A
5860973 Michelson Jan 1999 A
5861041 Tienboon Jan 1999 A
5863293 Richelsoph Jan 1999 A
5863465 Kinlen Jan 1999 A
5865846 Bryan et al. Feb 1999 A
5865848 Baker Feb 1999 A
5888220 Felt et al. Mar 1999 A
5888226 Rogozinski Mar 1999 A
5893889 Harrington Apr 1999 A
5895427 Kuslich et al. Apr 1999 A
5895428 Berry Apr 1999 A
5899941 Nishijima et al. May 1999 A
5928243 Guyer Jul 1999 A
5935133 Wagner et al. Aug 1999 A
5938663 Petreto Aug 1999 A
5951555 Rehak et al. Sep 1999 A
5961518 Errico et al. Oct 1999 A
5961554 Janson et al. Oct 1999 A
5964769 Wagner et al. Oct 1999 A
5976186 Bao et al. Nov 1999 A
5980522 Koros et al. Nov 1999 A
5984967 Zdeblick et al. Nov 1999 A
5989250 Wagner et al. Nov 1999 A
5989290 Biedermann et al. Nov 1999 A
5997539 Errico et al. Dec 1999 A
6001130 Bryan et al. Dec 1999 A
6017344 Errico et al. Jan 2000 A
6019792 Cauthen Feb 2000 A
6022376 Assell et al. Feb 2000 A
6030389 Wagner et al. Feb 2000 A
6039763 Shelokov Mar 2000 A
6045552 Zucherman et al. Apr 2000 A
6045579 Hochschuler et al. Apr 2000 A
6053921 Wagner et al. Apr 2000 A
6063089 Errico et al. May 2000 A
RE36758 Fitz Jun 2000 E
6080193 Hochschuler et al. Jun 2000 A
6093205 Mcleod et al. Jul 2000 A
6096038 Michelson Aug 2000 A
6099531 Bonutti Aug 2000 A
6102950 Vaccaro Aug 2000 A
6106526 Harms et al. Aug 2000 A
6110210 Norton et al. Aug 2000 A
6113637 Gill et al. Sep 2000 A
6123707 Wagner et al. Sep 2000 A
6126689 Brett Oct 2000 A
6132430 Wagner et al. Oct 2000 A
6132464 Martin Oct 2000 A
6132465 Ray et al. Oct 2000 A
6136001 Michelson Oct 2000 A
6136031 Middleton Oct 2000 A
6139579 Steffee et al. Oct 2000 A
6146421 Gordon et al. Nov 2000 A
6146422 Lawson Nov 2000 A
6156067 Bryan et al. Dec 2000 A
6159244 Suddaby Dec 2000 A
6162252 Kuras et al. Dec 2000 A
6165218 Husson et al. Dec 2000 A
6179874 Cauthen Jan 2001 B1
6187048 Milner et al. Feb 2001 B1
6200348 Biedermann et al. Mar 2001 B1
6206924 Timm Mar 2001 B1
6214049 Gayer et al. Apr 2001 B1
6214050 Huene Apr 2001 B1
6217579 Koros Apr 2001 B1
6228118 Gordon May 2001 B1
6231609 Mehdizadeh May 2001 B1
6176882 Biedermann et al. Jun 2001 B1
6241730 Alby Jun 2001 B1
6264656 Michelson Jul 2001 B1
6290724 Marino Sep 2001 B1
6296664 Middleton Oct 2001 B1
6315797 Middleton Nov 2001 B1
6331179 Freid et al. Dec 2001 B1
6348071 Steffee et al. Feb 2002 B1
RE37665 Ralph et al. Apr 2002 E
6368350 Erickson Apr 2002 B1
6368351 Glenn et al. Apr 2002 B1
6371990 Ferree Apr 2002 B1
6375682 Fleischmann et al. Apr 2002 B1
6375683 Crozet et al. Apr 2002 B1
6391030 Wagner et al. May 2002 B1
6395032 Gauchet May 2002 B1
6395034 Suddaby May 2002 B1
6402784 Wardlaw Jun 2002 B1
6402785 Zdeblick et al. Jun 2002 B1
6409766 Brett Jun 2002 B1
6413259 Lyons et al. Jul 2002 B1
6416515 Wagner et al. Jul 2002 B1
6419703 Fallin et al. Jul 2002 B1
6419704 Ferree Jul 2002 B1
6436140 Liu et al. Aug 2002 B1
6440168 Cauthen Aug 2002 B1
6442814 Landry et al. Sep 2002 B1
6443990 Aebi et al. Sep 2002 B1
6447512 Landry et al. Sep 2002 B1
6447544 Michelson Sep 2002 B1
6447545 Bagby Sep 2002 B1
6451021 Ralph et al. Sep 2002 B1
6454769 Wagner et al. Sep 2002 B2
6454806 Cohen et al. Sep 2002 B1
6454807 Jackson Sep 2002 B1
6475218 Gournay et al. Nov 2002 B2
6478822 Leroux et al. Nov 2002 B1
6478823 Michelson Nov 2002 B1
6482207 Errico Nov 2002 B1
6482234 Weber et al. Nov 2002 B1
6488710 Besselink Dec 2002 B2
6491724 Ferree Dec 2002 B1
6500180 Foley et al. Dec 2002 B1
6500205 Michelson Dec 2002 B1
6500206 Bryan Dec 2002 B1
6520996 Manasas et al. Feb 2003 B1
6524312 Landry et al. Feb 2003 B2
6533817 Norton et al. Mar 2003 B1
6533818 Weber et al. Mar 2003 B1
6537320 Michelson Mar 2003 B1
6540748 Lombardo Apr 2003 B2
6558423 Michelson May 2003 B1
6558424 Thalgott May 2003 B2
6562040 Wagner et al. May 2003 B1
6562074 Gerbec et al. May 2003 B2
6565566 Wagner et al. May 2003 B1
6565605 Goble et al. May 2003 B2
6569442 Gan et al. May 2003 B2
6572653 Simonson Jun 2003 B1
6576016 Hochschuler et al. Jun 2003 B1
6579318 Varga et al. Jun 2003 B2
6579319 Goble et al. Jun 2003 B2
6582467 Teitelbaum et al. Jun 2003 B1
6592624 Fraser et al. Jul 2003 B1
6595992 Wagner et al. Jul 2003 B1
6595998 Johnson et al. Jul 2003 B2
6607530 Carl et al. Aug 2003 B1
6610091 Reiley Aug 2003 B1
6610094 Husson Aug 2003 B2
6613050 Wagner et al. Sep 2003 B1
6616671 Landry et al. Sep 2003 B2
6626904 Jammet et al. Sep 2003 B1
6626905 Schmiel et al. Sep 2003 B1
6635062 Ray et al. Oct 2003 B2
6641614 Wagner et al. Nov 2003 B1
6648893 Dudasik Nov 2003 B2
6648915 Sazy Nov 2003 B2
6648917 Gerbec et al. Nov 2003 B2
6666870 Dixon et al. Dec 2003 B2
6666891 Boehm, Jr. et al. Dec 2003 B2
6679915 Cauthen Jan 2004 B1
6682533 Dinsdale et al. Jan 2004 B1
6685742 Jackson Feb 2004 B1
6692495 Zacouto Feb 2004 B1
6706070 Wagner et al. Mar 2004 B1
6712819 Zucherman et al. Mar 2004 B2
6716247 Michelson Apr 2004 B2
6719796 Cohen et al. Apr 2004 B2
6723126 Berry Apr 2004 B1
6733531 Trieu May 2004 B1
6736850 Davis May 2004 B2
6743257 Castro Jun 2004 B2
6758861 Ralph et al. Jul 2004 B2
6773460 Jackson Aug 2004 B2
6802844 Ferree Oct 2004 B2
6811567 Reiley Nov 2004 B2
6821298 Jackson Nov 2004 B1
6852129 Gerbec et al. Feb 2005 B2
6863673 Gerbec et al. Mar 2005 B2
6893464 Kiester May 2005 B2
6896680 Michelson May 2005 B2
6902580 Fallin et al. Jun 2005 B2
6928284 Palat et al. Aug 2005 B2
6936070 Muhanna Aug 2005 B1
6936071 Marnay et al. Aug 2005 B1
6953477 Berry Oct 2005 B2
6962606 Michelson Nov 2005 B2
6964664 Freid et al. Nov 2005 B2
6966929 Mitchell Nov 2005 B2
6966930 Arnin et al. Nov 2005 B2
6974478 Reiley et al. Dec 2005 B2
6981989 Fleischmann et al. Jan 2006 B1
6991632 Ritland Jan 2006 B2
6994727 Khandkar et al. Feb 2006 B2
6997929 Manzi et al. Feb 2006 B2
7011685 Arnin et al. Mar 2006 B2
7018415 McKay Mar 2006 B1
7029475 Panjabi Apr 2006 B2
7060073 Frey et al. Jun 2006 B2
7060100 Ferree Jun 2006 B2
7083622 Simonson Aug 2006 B2
7083649 Zucherman et al. Aug 2006 B2
7090698 Goble et al. Aug 2006 B2
7101398 Dooris et al. Sep 2006 B2
7118579 Michelson Oct 2006 B2
7118580 Beyersdorff et al. Oct 2006 B1
7128760 Michelson Oct 2006 B2
7147664 Louis et al. Dec 2006 B2
7153310 Ralph et al. Dec 2006 B2
7198644 Schultz et al. Apr 2007 B2
7204852 Marnay et al. Apr 2007 B2
7204853 Gordon et al. Apr 2007 B2
7217291 Zucherman et al. May 2007 B2
7270681 Cauthen Sep 2007 B2
7273496 Mitchell Sep 2007 B2
7291150 Graf Nov 2007 B2
7291159 Graf Nov 2007 B2
7291173 Richelsoph et al. Nov 2007 B2
7311713 Johnson et al. Dec 2007 B2
7316714 Gordon et al. Jan 2008 B2
7318839 Malberg et al. Jan 2008 B2
7320707 Zucherman et al. Jan 2008 B2
7326250 Beaurain et al. Feb 2008 B2
7338525 Ferree Mar 2008 B2
7338527 Blatt et al. Mar 2008 B2
7364589 Eisermann Apr 2008 B2
7473276 Aebi et al. Jan 2009 B2
7476238 Panjabi Jan 2009 B2
7485146 Crook et al. Feb 2009 B1
7517359 Drewry et al. Apr 2009 B2
7547309 Bertagnoli et al. Jun 2009 B2
7550009 Arnin et al. Jun 2009 B2
7556651 Humphreys et al. Jul 2009 B2
7615068 Timm et al. Nov 2009 B2
7635379 Callahan et al. Dec 2009 B2
7682396 Beaurain et al. Mar 2010 B2
7699875 Timm et al. Apr 2010 B2
7708778 Gordon et al. May 2010 B2
7713287 Timm et al. May 2010 B2
7713288 Timm et al. May 2010 B2
7727280 McLuen Jun 2010 B2
7753958 Gordon et al. Jul 2010 B2
7771479 Humphreys et al. Aug 2010 B2
7785351 Gordon et al. Aug 2010 B2
7794480 Gordon et al. Sep 2010 B2
7799082 Gordon et al. Sep 2010 B2
7811309 Timm et al. Oct 2010 B2
7819801 Miles et al. Oct 2010 B2
7828849 Lim Nov 2010 B2
7896919 Belliard et al. Mar 2011 B2
7909869 Gordon et al. Mar 2011 B2
7909877 Krueger et al. Mar 2011 B2
7927374 Duggal et al. Apr 2011 B2
7931675 Panjabi et al. Apr 2011 B2
7942905 Lim et al. May 2011 B2
7951170 Jackson May 2011 B2
7959677 Landry et al. Jun 2011 B2
8043379 Moumene et al. Oct 2011 B2
8052723 Gordon et al. Nov 2011 B2
8062375 Glerum et al. Nov 2011 B2
8105382 Olmos et al. Jan 2012 B2
8118869 Gordon et al. Feb 2012 B2
8118870 Gordon et al. Feb 2012 B2
8118871 Gordon et al. Feb 2012 B2
8123810 Gordon et al. Feb 2012 B2
8128700 Delurio et al. Mar 2012 B2
8147550 Gordon et al. Apr 2012 B2
8157844 Gimbel et al. Apr 2012 B2
8162994 Gimbel et al. Apr 2012 B2
8172903 Gordon et al. May 2012 B2
8182514 Gimbel et al. May 2012 B2
8187330 Gimbel et al. May 2012 B2
8257440 Gordon et al. Sep 2012 B2
8267965 Gimbel et al. Sep 2012 B2
8303660 Abdou Nov 2012 B1
8377098 Landry et al. Feb 2013 B2
8388687 Gimbel et al. Mar 2013 B2
8398713 Weiman Mar 2013 B2
8414652 Moumene et al. Apr 2013 B2
8435298 Weiman May 2013 B2
8475461 Butler et al. Jul 2013 B2
8486148 Butler et al. Jul 2013 B2
8491659 Weiman Jul 2013 B2
8512407 Butler et al. Aug 2013 B2
8518120 Glerum et al. Aug 2013 B2
8523912 Gimbel et al. Sep 2013 B2
8556979 Glerum et al. Oct 2013 B2
8591553 Eisermann et al. Nov 2013 B2
8597358 Landry et al. Dec 2013 B2
8603168 Gordon et al. Dec 2013 B2
8632595 Weiman Jan 2014 B2
8647386 Gordon et al. Feb 2014 B2
8679183 Glerum et al. Mar 2014 B2
8685098 Glerum et al. Apr 2014 B2
8709086 Glerum Apr 2014 B2
8753398 Gordon et al. Jun 2014 B2
8940022 Landry et al. Jan 2015 B2
8940051 Gimbel et al. Jan 2015 B2
9066811 Landry et al. Jun 2015 B2
9320610 Alheidt et al. Apr 2016 B2
9717601 Miller Aug 2017 B2
10166117 Daffinson Jan 2019 B1
20010020476 Gan et al. Sep 2001 A1
20010032020 Besselink Oct 2001 A1
20020040243 Atalli et al. Apr 2002 A1
20020045945 Liu et al. Apr 2002 A1
20020065557 Goble et al. May 2002 A1
20020068977 Jackson Jun 2002 A1
20020072801 Michelson Jun 2002 A1
20020082701 Zdeblick et al. Jun 2002 A1
20020091390 Michelson Jul 2002 A1
20020095154 Atkinson et al. Jul 2002 A1
20020123806 Reiley Sep 2002 A1
20020128659 Michelson Sep 2002 A1
20020128714 Manasas et al. Sep 2002 A1
20020130112 Manasas et al. Sep 2002 A1
20020138077 Ferree Sep 2002 A1
20020143401 Michelson Oct 2002 A1
20030028250 Reiley et al. Feb 2003 A1
20030040802 Errico Feb 2003 A1
20030055427 Graf Mar 2003 A1
20030065396 Michelson Apr 2003 A1
20030069643 Ralph et al. Apr 2003 A1
20030074063 Gerbec et al. Apr 2003 A1
20030074066 Errico et al. Apr 2003 A1
20030074067 Errico et al. Apr 2003 A1
20030074068 Errico et al. Apr 2003 A1
20030074069 Errico et al. Apr 2003 A1
20030074070 Errico et al. Apr 2003 A1
20030074071 Errico et al. Apr 2003 A1
20030074072 Errico et al. Apr 2003 A1
20030074073 Errico et al. Apr 2003 A1
20030074074 Errico et al. Apr 2003 A1
20030135275 Garcia et al. Jul 2003 A1
20030135277 Bryan et al. Jul 2003 A1
20030139812 Gacia et al. Jul 2003 A1
20030149483 Michelson Aug 2003 A1
20030176923 Keller et al. Sep 2003 A1
20030191470 Ritland Oct 2003 A1
20030204259 Goble et al. Oct 2003 A1
20030204260 Ferree Oct 2003 A1
20030220643 Ferree Nov 2003 A1
20030225409 Freid et al. Dec 2003 A1
20030233145 Landry et al. Dec 2003 A1
20040006391 Reiley Jan 2004 A1
20040019353 Freid et al. Jan 2004 A1
20040030387 Landry et al. Feb 2004 A1
20040030389 Ferree Feb 2004 A1
20040039448 Pisharodi Feb 2004 A1
20040044411 Suddaby Mar 2004 A1
20040049190 Biedermann et al. Mar 2004 A1
20040049271 Biedermann et al. Mar 2004 A1
20040049272 Reiley Mar 2004 A1
20040049273 Reiley Mar 2004 A1
20040049274 Reiley Mar 2004 A1
20040049275 Reiley Mar 2004 A1
20040049276 Reiley Mar 2004 A1
20040049277 Reiley Mar 2004 A1
20040049278 Reiley Mar 2004 A1
20040049280 Cauthen Mar 2004 A1
20040049281 Reiley Mar 2004 A1
20040087947 Lim et al. May 2004 A1
20040093083 Branch et al. May 2004 A1
20040102774 Trieu May 2004 A1
20040106997 Lieberson Jun 2004 A1
20040117020 Frey et al. Jun 2004 A1
20040127989 Dooris et al. Jul 2004 A1
20040133278 Marino et al. Jul 2004 A1
20040133281 Khandkar et al. Jul 2004 A1
20040138662 Landry et al. Jul 2004 A1
20040138749 Zucherman Jul 2004 A1
20040143265 Landry et al. Jul 2004 A1
20040143332 Krueger et al. Jul 2004 A1
20040147928 Landry et al. Jul 2004 A1
20040153065 Lim Aug 2004 A1
20040167626 Geremakis et al. Aug 2004 A1
20040181223 Ritland Sep 2004 A1
20040181284 Simonson Sep 2004 A1
20040220567 Eisermann et al. Nov 2004 A1
20040236327 Paul et al. Nov 2004 A1
20040236329 Panjabi Nov 2004 A1
20040243240 Beaurain et al. Dec 2004 A1
20040254643 Jackson Dec 2004 A1
20040254644 Taylor Dec 2004 A1
20040267364 Carli et al. Dec 2004 A1
20040267369 Lyons et al. Dec 2004 A1
20050010295 Michelson Jan 2005 A1
20050015146 Louis et al. Jan 2005 A1
20050015149 Michelson Jan 2005 A1
20050021144 Malberg et al. Jan 2005 A1
20050027361 Reiley Feb 2005 A1
20050033432 Gordon et al. Feb 2005 A1
20050033437 Bao et al. Feb 2005 A1
20050033439 Gordon et al. Feb 2005 A1
20050043800 Paul et al. Feb 2005 A1
20050049590 Alleyne et al. Mar 2005 A1
20050060034 Berry Mar 2005 A1
20050085815 Harms et al. Apr 2005 A1
20050107881 Neville et al. May 2005 A1
20050113927 Malek May 2005 A1
20050124991 Jahng Jun 2005 A1
20050125061 Zucherman Jun 2005 A1
20050125062 Biedermann et al. Jun 2005 A1
20050131406 Reiley Jun 2005 A1
20050143818 Yuan et al. Jun 2005 A1
20050149020 Jahng Jul 2005 A1
20050149023 Ritland Jul 2005 A1
20050154461 Humphreys et al. Jul 2005 A1
20050154462 Zucherman et al. Jul 2005 A1
20050154465 Hodges et al. Jul 2005 A1
20050154466 Humphreys et al. Jul 2005 A1
20050159818 Blain Jul 2005 A1
20050171543 Timm et al. Aug 2005 A1
20050171608 Peterman et al. Aug 2005 A1
20050171610 Humphreys et al. Aug 2005 A1
20050177156 Timm et al. Aug 2005 A1
20050177157 Jahng Aug 2005 A1
20050177164 Walters et al. Aug 2005 A1
20050177166 Timm et al. Aug 2005 A1
20050182401 Timm et al. Aug 2005 A1
20050182409 Callahan et al. Aug 2005 A1
20050033431 Gordon et al. Sep 2005 A1
20050203517 Jahng et al. Sep 2005 A1
20050209697 Paponneau et al. Sep 2005 A1
20050209698 Gordon et al. Sep 2005 A1
20050222569 Panjabi Oct 2005 A1
20050228500 Kim et al. Oct 2005 A1
20050245930 Timm et al. Nov 2005 A1
20050251261 Peterman Nov 2005 A1
20050256578 Blatt et al. Nov 2005 A1
20050261771 Paul et al. Nov 2005 A1
20050117725 Parson Dec 2005 A1
20050273167 Triplett et al. Dec 2005 A1
20050273171 Gordon et al. Dec 2005 A1
20050273173 Gordon et al. Dec 2005 A1
20050273174 Gordon et al. Dec 2005 A1
20050273175 Gordon et al. Dec 2005 A1
20050278026 Gordon et al. Dec 2005 A1
20050283244 Gordon et al. Dec 2005 A1
20050283245 Gordon et al. Dec 2005 A1
20050283247 Gordon et al. Dec 2005 A1
20050283248 Gordon et al. Dec 2005 A1
20050288670 Panjabi et al. Dec 2005 A1
20060009768 Ritland Jan 2006 A1
20060009850 Frigg et al. Jan 2006 A1
20060015100 Panjabi et al. Jan 2006 A1
20060149385 McKay Jan 2006 A1
20060036240 Colleran Feb 2006 A1
20060036245 Stern Feb 2006 A1
20060084986 Grinberg et al. Apr 2006 A1
20060089717 Krishna et al. Apr 2006 A1
20060095132 Kirschman May 2006 A1
20060122701 Kiester Jun 2006 A1
20060129244 Ensign Jun 2006 A1
20060142759 Arnin et al. Jun 2006 A1
20060149228 Schlapfer et al. Jul 2006 A1
20060149229 Kwak et al. Jul 2006 A1
20060149278 Abdou Jul 2006 A1
20060149372 Paxson et al. Jul 2006 A1
20060149383 Arnin et al. Jul 2006 A1
20060155377 Beaurain et al. Jul 2006 A1
20060167547 Suddaby Jul 2006 A1
20060189983 Fallin et al. Aug 2006 A1
20060195114 Bertagnoli Aug 2006 A1
20060195191 Sweeney et al. Aug 2006 A1
20060195192 Gordon et al. Aug 2006 A1
20060217712 Mueller et al. Sep 2006 A1
20060229729 Gordon Oct 2006 A1
20060241642 Arnin et al. Oct 2006 A1
20060241769 Gordon et al. Oct 2006 A1
20060241770 Rhoda et al. Oct 2006 A1
20060241771 Gordon et al. Oct 2006 A1
20060247635 Gordon et al. Nov 2006 A1
20060247779 Gordon et al. Nov 2006 A1
20060253201 McLuen Nov 2006 A1
20060260483 Hartmann et al. Nov 2006 A1
20060264937 White Nov 2006 A1
20060265068 Schwab Nov 2006 A1
20060265074 Krishna Nov 2006 A1
20070010886 Banick Jan 2007 A1
20070073405 Verhulst et al. Mar 2007 A1
20070073406 Gordon et al. Mar 2007 A1
20070093828 Abdou Apr 2007 A1
20070093846 Frigg et al. Apr 2007 A1
20070162137 Kloss et al. Jul 2007 A1
20070225814 Atkinson Jul 2007 A1
20070213720 Gordon et al. Sep 2007 A1
20070213821 Kwak et al. Sep 2007 A1
20070239279 Francis Oct 2007 A1
20070270814 Lim et al. Nov 2007 A1
20070270838 Bruneau et al. Nov 2007 A1
20070270972 Gordon et al. Nov 2007 A1
20070288094 Krishna et al. Dec 2007 A1
20080015702 Lakin et al. Jan 2008 A1
20080021285 Drzyzga et al. Jan 2008 A1
20080027547 Yu et al. Jan 2008 A1
20080033562 Krishna Feb 2008 A1
20080065079 Bruneau et al. Mar 2008 A1
20080133013 Duggal et al. Jun 2008 A1
20080140207 Olmos et al. Jun 2008 A1
20080147193 Matthis et al. Jun 2008 A1
20080161853 Arnold et al. Jul 2008 A1
20080177310 Reiley Jul 2008 A1
20080183204 Greenhalgh et al. Jul 2008 A1
20080234732 Landry et al. Sep 2008 A1
20080234740 Landry et al. Sep 2008 A1
20080234741 Landry et al. Sep 2008 A1
20080234764 Landry et al. Sep 2008 A1
20080234823 Landry et al. Sep 2008 A1
20080300685 Carls et al. Dec 2008 A1
20080312692 Brennan et al. Dec 2008 A1
20090005817 Friedrich et al. Jan 2009 A1
20090076549 Lim et al. Mar 2009 A1
20090088847 Krishna et al. Apr 2009 A1
20090093846 Hestad Apr 2009 A1
20090105757 Gimbel et al. Apr 2009 A1
20090105758 Gimbel et al. Apr 2009 A1
20090105759 Gimbel et al. Apr 2009 A1
20090105764 Jackson Apr 2009 A1
20090105820 Jackson Apr 2009 A1
20090105827 Gimbel et al. Apr 2009 A1
20090105828 Gimbel et al. Apr 2009 A1
20090105829 Gimbel et al. Apr 2009 A1
20090143862 Trieu Jun 2009 A1
20090177196 Zlock et al. Jul 2009 A1
20090270870 Zubok et al. Oct 2009 A1
20100030336 Cope Feb 2010 A1
20100082109 Greenhalgh et al. Apr 2010 A1
20100174317 Timm et al. Jul 2010 A1
20100191336 Greenhalgh Jul 2010 A1
20100204795 Greenhalgh Aug 2010 A1
20100211176 Greenhalgh Aug 2010 A1
20100222819 Timm et al. Sep 2010 A1
20100222884 Greenhalgh Sep 2010 A1
20100292796 Greenhalgh et al. Nov 2010 A1
20100298941 Hes et al. Nov 2010 A1
20100331985 Gordon et al. Dec 2010 A1
20110015742 Hong Jan 2011 A1
20110196428 Panjabi et al. Aug 2011 A1
20110319997 Glerum et al. Dec 2011 A1
20120035729 Glerum et al. Feb 2012 A1
20120059470 Weiman Mar 2012 A1
20120143254 Gimbel et al. Jun 2012 A1
20120232552 Morgenstern Lopez et al. Sep 2012 A1
20120245689 Gimbel et al. Sep 2012 A1
20120265309 Glerum et al. Oct 2012 A1
20120310349 Gordon et al. Dec 2012 A1
20120330421 Weiman Dec 2012 A1
20130023994 Glerum Jan 2013 A1
20130158667 Tabor et al. Jun 2013 A1
20130158669 Sungarian et al. Jun 2013 A1
20130190876 Drochner et al. Jul 2013 A1
20130204371 McLuen et al. Aug 2013 A1
20130211525 McLuen Aug 2013 A1
20130211526 Alheidt et al. Aug 2013 A1
20130245769 Gimbel et al. Sep 2013 A1
20140067071 Man et al. Mar 2014 A1
20140277500 Logan Sep 2014 A1
20180200075 Baker Jul 2018 A1
Foreign Referenced Citations (34)
Number Date Country
1090595 Nov 2001 EP
2716616 Sep 1995 FR
2718946 Oct 1995 FR
2735351 Dec 1996 FR
2745706 Sep 1997 FR
2799949 Apr 2001 FR
2085145 Jul 1997 RU
WO 9848739 Nov 1998 WO
WO 2000004851 Feb 2000 WO
WO 2000074606 Dec 2000 WO
WO 2001001893 Jan 2001 WO
WO 2001056513 Aug 2001 WO
WO 2002045625 Jun 2002 WO
WO 2004019762 Mar 2004 WO
WO 2004019828 Mar 2004 WO
WO 2004019830 Mar 2004 WO
WO 2004024011 Mar 2004 WO
WO 2004026188 Apr 2004 WO
WO 2004041129 May 2004 WO
WO 2004054479 Jul 2004 WO
WO 2005016194 Feb 2005 WO
WO 2005067824 Jul 2005 WO
WO 2005070349 Aug 2005 WO
WO 2005117725 Dec 2005 WO
WO 2006002359 Jan 2006 WO
WO 2006047587 May 2006 WO
WO 2006057698 Jun 2006 WO
WO 2006066198 Jun 2006 WO
WO 2006116851 Nov 2006 WO
WO 2006119447 Nov 2006 WO
WO 2007104024 Sep 2007 WO
WO 2008089350 Jul 2008 WO
WO 2012134980 Oct 2012 WO
WO 2013023098 Feb 2013 WO
Non-Patent Literature Citations (220)
Entry
Case IPR2015-01721: EX1005: Declaration of Jorge A. Ochoa, P.E.
Case IPR2015-01721: EX1020: Claim chart—Claims 1 and 2 vs. U.S. Pat. No. 5,782,832 to Larsen et al.
Case IPR2015-01749. EX1002: Flexuspine, Inc. v. Globus Medical Inc., U.S. District Court for the Eastern District of Texas, Civil Action No. 15-cv-00201-JRG-KNMFiexuspine, Inc.'s Claim Chart for P.R. 3-1 Infringement Contentions.
Case IPR2015-01749. EX1007: Declaration of Jorge A. Ochoa, P .E.
Case IPR2015-01749. EX1008: Curriculum Vitae of Jorge A. Ochoa, P.E.
Case IPR2015-01749. EX1013: Blumenthal SL, Ohnmeiss DO. Intervertebral cages for degenerative spinal diseases. Spine J. Jui-Aug. 2003;3(4):301-309.
Case IPR2015-01749. EX1014: Dooris AP, Gael VK, Grosland NM, Gilbertson LG, Wilder DG. Load-sharing between anterior and posterior elements in a lumbar motion segment implanted with an artificial disc. Spine (Phila Pa 1976). 2001 ;26(6):E122-129.
Case IPR2015-01749. EX1015: Mayer HM, Wiechert K, Korge A, Oose I. Minimally invasive total disc replacement: surgical technique and preliminary clinical results. Eur Spine J. Oct. 2002;11 Suppi2:S124-30.
Case IPR2015-01749. EX1016: Foley KT, Holly LT, Schwender JD. Minimally invasive lumbar fusion. Spine (Phila Pa 1976). Aug. 1, 2003;28(15 Suppi):S26-35.
Case IPR2015-01749. EX1017: Tropiano P, Huang RC, Girardi FP, Mamay T. Lumbar disc replacement: preliminary results with ProDisc II after a minimum follow-up period of 1 year. J Spinal Disord Tech. Aug. 2003;16(4):362-8.
Case IPR2015-01749. EX1018: Felman Y, Lee S-H, Silvera JR, Gepstein R. Posterior Lumbar Interbody Fusion for Degenerative Disc Disease Using a Minimally Invasive B-Twin Expandable Spinal Spacer: a multicenter study. J Spinal Disord Tech . . . 2003; 16(5):455-460.
Case IPR2015-01749. EX1019: Wagner PC, Bagby GW, Grant BD, Gallina A, Ratzlaff M, SandeR. Surgical stabilization of the equine cervical spine. Vet Surg 1979 8:7-12.
Case IPR2015-01749. EX1020: Weiner BK, Fraser RD. Spine update lumbar interbody cages. Spine. Mar. 1, 1998; 23 (5):634-40.
Case IPR2015-01749. EX1021: Zeegers WS, Bohnen LM, Laaper M, Verhaegen MJ. Artificial disc replacement with the modular type SB Charite III: 2-year results in 50 prospectively studied patients. Eur Spine J. 1999;8 (3):210-217.
Case IPR2015-01749. EX1023: Claim chart: Claim 1 vs. U.S. Pat. No. 6,454,806.
Case IPR2015-01749. EX1024: Claim chart: Claim 1 vs. U.S. Pat. No. 5,782,832 in view of U.S. Patent No. 6,491 ,724.
Case IPR2015-01749. EX1025: Claim Chart: Claim 5 vs. U.S. Pat. No. 5,522,899.
Case IPR2015-01755: EX1006: Declaration of Jorge A. Ochoa, P .E.
Case IPR2015-01755: EX1018: Claim chart—Claim 23 vs. U.S. Pat. No. 6,595,998.
Case IPR2015-01755: EX1019: Claim chart—Claim 37 vs. U.S. Pat. No. 6,595,998.
Case IPR2015-01755: EX1020: Claim chart—Claim 37 vs. U.S. Pat. No. 6,176,882.
Case IPR2015-01795: EX1005: Declaration of Jorge A. Ochoa, P.E.
Case IPR2015-01795: EX1017: Claim chart—Claims 1-4 vs. U.S. Pat. No. 6,595,998- Ground 1.
Case IPR2015-01795: EX1018: Claim chart—Claims 1-4 vs. U.S. Pat. No. 6,595,998- Ground 2.
Case IPR2015-01830: EX1006: Declarati_on of Jorge A. Ochoa, P.E.
Case IPR2015-01830: EX1021: Claim chart—Claim 17 vs. U.S. Pat. No. 7,828,849.
Case IPR2015-01830: EX1022: Claim chart—Claim 17 vs. U.S. Pat. No. 6,595,998.
Co-pending U.S. Appl. No. 13/072,511 entitled “Instrumentation for Artificial Functional Spinal Unit System” to Gimbel et al., filed Mar. 25, 2011.
Co-pending U.S. Appl. No. 13/437,604 entitled “Method of Inserting an Expandable Intervertebral Implant Without Overdistraction” to Gordon et al., filed Apr. 2, 2012.
Co-pending U.S. Appl. No. 13/784,224 entitled “Interbody Device Insertion Systems and Methods” to Gimbel et al., filed Mar. 4, 2013.
Co-pending U.S. Appl. No. 13/306,535 entitled “Posterior Stabilization Systems With Shared, Dual Dampener Systems” to Gimbel et al., filed Nov. 29, 2011.
Co-pending U.S. Appl. No. 13/967,776 entitled “Expandable Intervertebral Implant” to Gordon et al., filed Aug. 15, 2013.
Co-pending U.S. Appl. No. 14/185,561 entitled “Expandable Fusion Device for Positioning Between Adjacent Vertebral Bodies” to Wagner, filed Feb. 20, 2014.
E.P. Communication Pursuant to Article 94(3) EPC for Application No. 08713804.6-2310 dated Dec. 5, 2013.
E.P. Communication Pursuant to Article 94(3) EPC for Application No. 08713804.6-2310 dated Jan. 22, 2013.
E.P.O. Communication Pursuant to Article 94(3) for European Application No. 07 758 171.8 dated Feb. 26, 2013.
E.P.O. Communication Pursuant to Article 94(3) for European Application No. 07 758 171.8-2310 dated Oct. 11, 2012.
E.P.O. Decision to Grant for European Application No. 07 758 171.8 dated May 30, 2014.
E.P.O. Notice of Intent to Grant for European Application No. 07 758 171.8 dated Feb. 26, 2013.
E.P.O. Report of Deficiencies for European Application No. 07 758 171.8-2310 dated Feb. 13, 2012.
Hodges et al., “Biomechanics of the Kenti (TM) Total Joint Replacement”, Presented at the Global Symposium on Motion Preservation Technology, May 9-13, 2006; 1 page.
Humphreys et al., “Biomechanics of the KENTI (TM) Total Joint Replacement”, Presented at the Global Symposium on Motion Preservation Technology, May 9-13, 2006; 3 pages.
International Preliminary Report on Patentability for International Application No. PCT/US2008/051346 dated Mar. 27, 2009, 23 pages.
International Preliminary Report on Patentability for International Application No. PCT/US2012/030248 dated Oct. 23, 2012, 11 pages.
International Search Report and Written Opinion for International Application No. PCT/US2008/051346 dated Sep. 9, 2008, 20 pages.
J.P. Final Decision of Rejection for Japanese Application No. 2008-558536 considered by Examiner dated Sep. 4, 2012.
J.P. Notice of Reason for Refusal for Japanese Application No. 2008-558536 considered by Examiner dated Jan. 12, 2012. Attorney Docket No. 5943-00907.
J.P. Notice of Reason for Refusal for Japanese Application No. 2009-546510 dated Mar. 6, 2012.
J.P. Notice of Reason for Refusal for Japanese Application No. 2009-546510 dated Oct. 9, 2012.
Khoueir et al. “Classification of posterior dynamic stabilization devices,” Neurosurg Focus, 2007, 22(1):E1, 8 pages.
Patel et al., “Changes in Kinematics following Single Level fusion, Single and Bi-Level Charite disc replacement in the Lumbar Spine” Presented at the Global Symposium on Motion Preservation Technology, May 9-13, 2006; 1 page.
PCT Search Report and Written Opinion for International Application No. PCT/US2007/063595 dated Dec. 11, 2007, 15 pages.
PCT Search Report and Written Opinion for PCT/US2004/025090 dated Apr. 11, 2005 (23 pages).
Petition for Inter Partes Review of U.S. Pat. No. 7,204,853 filed Aug. 17, 2015. Petitioner: Globus Medical, Inc. v. Patent Owner: Flexuspine, Inc. Case IPR2015-01749.
Petition for Inter Partes Review of U.S. Pat. No. 7,316,714 filed Aug. 14, 2015. Petitioner: Globus Medical, Inc. v. Patent Owner: Flexuspine, Inc. Case IPR2015-01721.
Petition for Inter Partes Review of U.S. Pat. No. 7,909,869 filed Aug. 18, 2015. Petitioner: Globus Medical, Inc. v. Patent Owner: Flexuspine, Inc. Case IPR2015-01755.
Petition for Inter Partes Review of U.S. Pat. No. 8,647,386 filed Aug. 24, 2015. Petitioner: Globus Medical, Inc. v. Patent Owner: Flexuspine, Inc. Case IPR2015-01795.
Petition for Inter Partes Review of U.S. Patent No. 8, 123,810 filed Aug. 27, 2015. Petitioner: Globus Medical, Inc. v. Patent Owner: Flexuspine, Inc. Case IPR2015-01830.
Serhan et al. “Biomechanics of the posterior lumbar articulating elements,” Neurosurg Focus 2007, 22(1 ):E1, 6 pages.
U.S. Patent and Trademark Office “Communication” for U.S. Appl. No. 10/777,411 dated Aug. 29, 2008.
U.S. Patent and Trademark Office “Communication” for U.S. Appl. No. 10/777,411 dated Dec. 23, 2008.
U.S. Patent and Trademark Office “Communication” for U.S. Appl. No. 10/777,411 dated Mar. 19, 2007.
U.S. Patent and Trademark Office “Communication” for U.S. Appl. No. 10/777,411 dated Mar. 20, 2008.
U.S. Patent and Trademark Office “Communication” for U.S. Appl. No. 10/777,411 dated Sep. 24, 2007.
U.S. Patent and Trademark Office “Communication” for U.S. Appl. No. 10/777,411, dated Jul. 17, 2009.
U.S. Patent and Trademark Office “Communication” for U.S. Appl. No. 10/777,411, dated Jun. 9, 2010.
U.S. Patent and Trademark Office “Communication” for U.S. Appl. No. 10/777,411, dated Mar. 5, 2010.
U.S. Patent and Trademark Office “Communication” for U.S. Appl. No. 10/777,411, dated Oct. 1, 2009.
U.S. Patent and Trademark Office “Communication” for U.S. Appl. No. 10/777,411, dated Oct. 15, 2010.
U.S. Patent and Trademark Office “Communication” for U.S. Appl. No. 11/050,632 dated Apr. 6, 2009.
U.S. Patent and Trademark Office “Communication” for U.S. Appl. No. 11/050,632 dated Sep. 24, 2008.
U.S. Patent and Trademark Office “Communication” for U.S. Appl. No. 11/050,632, dated Aug. 25, 2009.
U.S. Patent and Trademark Office “Communication” for U.S. Appl. No. 11/050,632, dated Mar. 2, 2010.
U.S. Patent and Trademark Office “Communication” for U.S. Appl. No. 11/134,055 dated Aug. 25, 2008.
U.S. Patent and Trademark Office “Communication” for U.S. Appl. No. 11/134,055, dated Jan. 19, 2010.
U.S. Patent and Trademark Office “Communication” for U.S. Appl. No. 11/134,066 dated Dec. 4, 2008.
U.S. Patent and Trademark Office “Communication” for U.S. Appl. No. 11/134,066, dated Feb. 18, 2010.
U.S. Patent and Trademark Office “Communication” for U.S. Appl. No. 11/134,066, dated Sep. 9, 2009.
U.S. Patent and Trademark Office “Communication” for U.S. Appl. No. 11/134,067, dated Aug. 14, 2009.
U.S. Patent and Trademark Office “Communication” for U.S. Appl. No. 11/134,067, dated Feb. 18, 2010.
U.S. Patent and Trademark Office “Communication” for U.S. Appl. No. 11/134,069 dated Dec. 24, 2008.
U.S. Patent and Trademark Office “Communication” for U.S. Appl. No. 11/134,069 dated Jun. 5, 2009.
U.S. Patent and Trademark Office “Communication” for U.S. Appl. No. 11/134,069, dated Apr. 19, 2010.
U.S. Patent and Trademark Office “Communication” for U.S. Appl. No. 11/134,069, dated Dec. 30, 2009.
U.S. Patent and Trademark Office “Communication” for U.S. Application No. 11 /134,073, dated Jan. 27, 2010.
U.S. Patent and Trademark Office “Communication” for U.S. Appl. No. 11/134,073, dated Jul. 22, 2009.
U.S. Patent and Trademark Office “Communication” for U.S. Appl. No. 11/134,079, dated Aug. 14, 2009.
U.S. Patent and Trademark Office “Communication” for U.S. Appl. No. 11/134,079, dated Feb. 19, 2010.
U.S. Patent and Trademark Office “Communication” for U.S. Appl. No. 11/134,082 dated Dec. 3, 2008.
U.S. Patent and Trademark Office “Communication” for U.S. Appl. No. 11/134,082, dated Aug. 14, 2009.
U.S. Patent and Trademark Office “Communication” for U.S. Appl. No. 11/134,082, dated Mar. 12, 2010.
U.S. Patent and Trademark Office “Communication” for U.S. Appl. No. 11/134,082, dated May 25, 2010.
U.S. Patent and Trademark Office “Communication” for U.S. Appl. No. 11/134,091 dated Dec. 24, 2008.
U.S. Patent and Trademark Office “Communication” for U.S. Appl. No. 11/134,091 dated Feb. 21, 2008.
U.S. Patent and Trademark Office “Communication” for U.S. Appl. No. 11/134,091, dated Aug. 4, 2010.
U.S. Patent and Trademark Office “Communication” for U.S. Appl. No. 11 /134,091, dated Jan. 26, 2010.
U.S. Patent and Trademark Office “Communication” for U.S. Appl. No. 11/134,092 dated Feb. 21, 2008.
U.S. Patent and Trademark Office “Communication” for U.S. Appl. No. 11/343,933 dated Jun. 30, 2008.
U.S. Patent and Trademark Office “Communication” for U.S. Appl. No. 11/343,933 dated Nov. 19, 2007.
U.S. Patent and Trademark Office “Communication” for U.S. Appl. No. 11/345,602 dated Mar. 31, 2009.
U.S. Patent and Trademark Office “Communication” for U.S. Appl. No. 11/345,602, dated Oct. 13, 2009.
U.S. Patent and Trademark Office “Communication” for U.S. Appl. No. 11/371,170, dated Jan. 28, 2011.
U.S. Patent and Trademark Office “Communication” for U.S. Appl. No. 11/371,170, dated Jul. 12, 2010.
U.S. Patent and Trademark Office “Communication” for U.S. Appl. No. 11/371,170, dated May 6, 2011.
U.S. Patent and Trademark Office “Communication” for U.S. Appl. No. 11/371,170, dated May 4, 2010.
U.S. Patent and Trademark Office “Communication” for U.S. Appl. No. 11/371,170, dated Nov. 4, 2009.
U.S. Patent and Trademark Office “Communication” for U.S. Appl. No. 11/371,181, dated Oct. 11, 2007.
U.S. Patent and Trademark Office “Communication” for U.S. Appl. No. 11/371,182, dated Apr. 24, 2009.
U.S. Patent and Trademark Office “Communication” for U.S. Appl. No. 11/371,182, dated Aug. 25, 2010.
U.S. Patent and Trademark Office “Communication” for U.S. Appl. No. 11/371,182, dated Dec. 12, 2008.
U.S. Patent and Trademark Office “Communication” for U.S. Appl. No. 11/371,182, dated Feb. 8, 2010.
U.S. Patent and Trademark Office “Communication” for U.S. Appl. No. 11/371,182, dated Jul. 21, 2009.
U.S. Patent and Trademark Office “Communication” for U.S. Appl. No. 11/371,182, dated Jun. 8, 2010.
U.S. Patent and Trademark Office “Communication” for U.S. Appl. No. 11/371,182, dated Jun. 9, 2008.
U.S. Patent and Trademark Office “Communication” for U.S. Appl. No. 11/371,182, dated Mar. 25, 2009.
U.S. Patent and Trademark Office “Communication” for U.S. Appl. No. 11/371,182, dated Oct. 11, 2007.
U.S. Patent and Trademark Office “Communication” for U.S. Appl. No. 11/371,182, dated Oct. 14, 2009.
U.S. Patent and Trademark Office “Communication” for U.S. Appl. No. 11/371,188, dated Apr. 28, 2010.
U.S. Patent and Trademark Office “Communication” for U.S. Appl. No. 11/371,188, dated Jun. 15, 2010.
U.S. Patent and Trademark Office “Communication” for U.S. Appl. No. 11/371,188, dated Mar. 17, 2009.
U.S. Patent and Trademark Office “Communication” for U.S. Appl. No. 11/371,188, dated Sep. 1, 2010.
U.S. Patent and Trademark Office “Communication” for U.S. Appl. No. 11/371,188, dated Sep. 25, 2009.
U.S. Patent and Trademark Office “Communication” for U.S. Appl. No. 11/371,190, dated Apr. 29, 2009.
U.S. Patent and Trademark Office “Communication” for U.S. Appl. No. 11/371,190, dated Apr. 17, 2008.
U.S. Patent and Trademark Office “Communication” for U.S. Appl. No. 11/371,190, dated Aug. 11, 2008.
U.S. Patent and Trademark Office “Communication” for U.S. Appl. No. 11/371,190, dated Aug. 11, 2010.
U.S. Patent and Trademark Office “Communication” for U.S. Appl. No. 11/371,190, dated Feb. 26, 2010.
U.S. Patent and Trademark Office “Communication” for U.S. Appl. No. 11/371,190, dated Nov. 7, 2008.
U.S. Patent and Trademark Office “Communication” for U.S. Appl. No. 11/371,190, dated Oct. 11, 2007.
U.S. Patent and Trademark Office “Communication” for U.S. Appl. No. 11/371,190, dated Oct. 29, 2009.
U.S. Patent and Trademark Office “Communication” for U.S. Appl. No. 11/371,328, dated Dec. 30, 2009.
U.S. Patent and Trademark Office “Communication” for U.S. Appl. No. 11/371,328, dated Jan. 6, 2011.
U.S. Patent and Trademark Office “Communication” for U.S. Appl. No. 11/371,328, dated Jun. 17, 2010.
U.S. Patent and Trademark Office “Communication” for U.S. Appl. No. 11/371,328, dated Mar. 17, 2009.
U.S. Patent and Trademark Office “Communication” for U.S. Appl. No. 11/371,328, dated Sep. 28, 2009.
U.S. Patent and Trademark Office “Communication” for U.S. Appl. No. 11/371,376, dated Apr. 20, 2009.
U.S. Patent and Trademark Office “Communication” for U.S. Appl. No. 11/371,376, dated Aug. 28, 2009.
U.S. Patent and Trademark Office “Communication” for U.S. Appl. No. 11/371,376, dated Jul. 29, 2010.
U.S. Patent and Trademark Office “Communication” for U.S. Appl. No. 11/371,376, dated May 26, 2010.
U.S. Patent and Trademark Office “Communication” for U.S. Appl. No. 11/371,376, dated Nov. 29, 2007.
U.S. Patent and Trademark Office “Communication” for U.S. Appl. No. 11/371,376, dated Nov. 4, 2009.
U.S. Patent and Trademark Office “Communication” for U.S. Appl. No. 11/526,849, dated Dec. 6, 2010.
U.S. Patent and Trademark Office “Communication” for U.S. Appl. No. 11/526,849, dated Feb. 23, 2011.
U.S. Patent and Trademark Office “Communication” for U.S. Application No. 11 /526,849, dated Jun. 1, 2010.
U.S. Patent and Trademark Office “Communication” for U.S. Appl. No. 11/655,723, dated May 27, 2009.
U.S. Patent and Trademark Office “Communication” for U.S. Appl. No. 11/655,723, dated Nov. 24, 2009.
U.S. Patent and Trademark Office “Communication” for U.S. Appl. No. 11/655,724, dated May 27, 2009.
U.S. Patent and Trademark Office “Communication” for U.S. Appl. No. 11/655,737, dated May 27, 2009.
U.S. Patent and Trademark Office “Communication” for U.S. Appl. No. 11/655,724, dated Nov. 23, 2009.
U.S. Patent and Trademark Office “Communication” for U.S. Appl. No. 11/655,737, dated Nov. 23, 2009.
U.S. Patent and Trademark Office “Communication” for U.S. Appl. No. 11/655,787, dated May 27, 2009.
U.S. Patent and Trademark Office “Communication” for U.S. Appl. No. 11/655,787, dated Nov. 23, 2009.
U.S. Patent and Trademark Office “Communication” for U.S. Appl. No. 11/655,790, dated Jun. 4, 2009.
U.S. Patent and Trademark Office “Communication” for U.S. Appl. No. 11/655,790, dated Mar. 15, 2010.
U.S. Patent and Trademark Office “Communication” for U.S. Appl. No. 11/975,916, dated Aug. 4, 2010.
U.S. Patent and Trademark Office “Communication” for U.S. Appl. No. 11/975,916, dated Feb. 9, 2011.
U.S. Patent and Trademark Office “Communication” for U.S. Appl. No. 11/975,917, dated Aug. 17, 2010.
U.S. Patent and Trademark Office “Communication” for U.S. Appl. No. 11/975,917, dated Feb. 4, 2011.
U.S. Patent and Trademark Office “Communication” for U.S. Application No. 11 /975,919, dated Aug. 19, 2010.
U.S. Patent and Trademark Office “Communication” for U.S. Appl. No. 11/975,919, dated Feb. 4, 2011.
U.S.P.T.O. Non-Final Office Action for U.S. Appl. No. 11/655,737, dated Mar. 15, 2013.
U.S.P.T.O. Non-Final Office Action for U.S. Appl. No. 11/975,918, dated Aug. 15, 2011.
U.S.P.T.O. Advisory Action for U.S. Appl. No. 11/134,055, dated Feb. 15, 2012.
U.S.P.T.O. Advisory Action for U.S. Appl. No. 11/134,055, dated Jul. 8, 2013.
U.S.P.T.O. Advisory Action for U.S. Appl. No. 11/371,170, dated Aug. 5, 2011.
U.S.P.T.O. Advisory Action for U.S. Appl. No. 12/841,792, dated Jul. 19, 2012
U.S.P.T.O. Advisory Action for U.S. Appl. No. 13/306,535, dated Sep. 9, 2013.
U.S.P.T.O. Final Office Action for U.S. Appl. No. 11/134,055, dated Apr. 18, 2013.
U.S.P.T.O. Final Office Action for U.S. Appl. No. 11/134,055, dated Nov. 14, 2011.
U.S.P.T.O. Final Office Action for U.S. Appl. No. 11/134,091, dated Feb. 10, 2012.
U.S.P.T.O. Final Office Action for U.S. Appl. No. 11/345,602, dated Aug. 13, 2012.
U.S.P.T.O. Final Office Action for U.S. Appl. No. 11/371,376, dated Oct. 16, 2012.
U.S.P.T.O. Final Office Action for U.S. Appl. No. 11/655,723, dated Dec. 26, 2014.
U.S.P.T.O. Final Office Action for U.S. Appl. No. 11/655,724, dated Aug. 24, 2012.
U.S.P.T.O. Final Office Action for U.S. Appl. No. 11/975,916, dated Sep. 6, 2011.
U.S.P.T.O. Final Office Action for U.S. Appl. No. 11/975,919, dated Jan. 27, 2012.
U.S.P.T.O. Final Office Action for U.S. Appl. No. 12/841,792, dated Mar. 23, 2012.
U.S.P.T.O. Final Office Action for U.S. Appl. No. 13/306,535, dated Jul. 18, 2013.
U.S.P.T.O. Non-Final Office Action for U.S. Appl. No. 10/634,950, dated Dec. 1, 2005.
U.S.P.T.O. Non-Final Office Action for U.S. Appl. No. 11/134,055, dated Jun. 9, 2011.
U.S.P.T.O. Non-Final Office Action for U.S. Appl. No. 11/134,055, dated Nov. 8, 2012.
U.S.P.T.O. Non-Final Office Action for U.S. Appl. No. 11/134,091, dated Aug. 12, 2011.
U.S.P.T.O. Non-Final Office Action for U.S. Appl. No. 11/345,602, dated Mar. 5, 2012.
U.S.P.T.O. Non-Final Office Action for U.S. Appl. No. 11/371,376, dated Mar. 23, 2012.
U.S.P.T.O. Non-Final Office Action for U.S. Appl. No. 11/655,723, dated May 20, 2014.
U.S.P.T.O. Non-Final Office Action for U.S. Appl. No. 11/655,724, dated Feb. 17, 2012.
U.S.P.T.O. Non-Final Office Action for U.S. Appl. No. 11/655,787, dated May 20, 2014.
U.S.P.T.O. Non-Final Office Action for U.S. Appl. No. 11/975,917, dated Aug. 3, 2011.
U.S.P.T.O. Non-Final Office Action for U.S. Appl. No. 11/975,919, dated Jul. 21, 2011.
U.S.P.T.O. Non-Final Office Action for U.S. Appl. No. 11/975,920, dated Jun. 7, 2011.
U.S.P.T.O. Non-Final Office Action for U.S. Appl. No. 11/975,921, dated Jun. 9, 2011.
U.S.P.T.O. Non-Final Office Action for U.S. Appl. No. 12/841,792, dated Oct. 20, 2011.
U.S.P.T.O. Non-Final Office Action for U.S. Appl. No. 13/306,535, dated Aug. 24, 2012.
U.S.P.T.O. Non-Final Office Action for U.S. Appl. No. 13/306,535, dated May 24, 2012.
U.S.P.T.O. Non-Final Office Action for U.S. Appl. No. 13/437,604, dated Jul. 2, 2014.
U.S.P.T.O. Non-Final Office Action for U.S. Appl. No. 14/185,561, dated May 5, 2015.
U.S.P.T.O. Notice of Allowance for U.S. Appl. No. 11/134,055, dated Feb. 19, 2014.
U.S.P.T.O. Notice of Allowance for U.S. Appl. No. 11/134,055, dated May 5, 2014.
U.S.P.T.O. Notice of Allowance for U.S. Appl. No. 11/134,067, dated Oct. 3, 2011.
U.S.P.T.O. Notice of Allowance for U.S. Appl. No. 11/134,069, dated Oct. 13, 2011.
U.S.P.T.O. Notice of Allowance for U.S. Appl. No. 11/134,073, dated Oct. 13, 2011.
U.S.P.T.O. Notice of Allowance for U.S. Appl. No. 11/134,079, dated Nov. 25, 2011.
U.S.P.T.O. Notice of Allowance for U.S. Appl. No. 11/134,082, dated Jan. 11, 2012.
U.S.P.T.O. Notice of Allowance for U.S. Appl. No. 11/134,091, dated May 4, 2012.
U.S.P.T.O. Noticeof Allowance for U.S. Appl. No. 11/371,170, dated Oct. 12, 2011.
U.S.P.T.O. Notice of Allowance for U.S. Appl. No. 11/371,328, dated Jun. 23, 2011.
U.S.P.T.O. Notice of Allowance for U.S. Appl. No. 11/655,723, dated Dec. 26, 2014.
U.S.P.T.O. Notice of Allowance for U.S. Appl. No. 11/655,724, dated Oct. 4, 2012.
U.S.P.T.O. Notice of Allowance for U.S. Appl. No. 11/655,787, dated Sep. 26, 2014.
U.S.P.T.O. Notice of Allowance for U.S. Appl. No. 11/655,790, dated Feb. 4, 2011.
U.S.P.T.O. Notice of Allowance for U.S. Appl. No. 11/975,916, dated Jan. 28, 2013.
U.S.P.T.O. Notice of Allowance for U.S. Appl. No. 11/975,917, dated Feb. 1, 2012.
U.S.P.T.O. Notice of Allowance for U.S. Appl. No. 11/975,918, dated Jan. 19, 2012.
U.S.P.T.O. Notice of Allowance for U.S. Appl. No. 11/975,919, dated May 11, 2012.
U.S.P.T.O. Notice of Allowance for U.S. Appl. No. 11/975,920, dated Nov. 16, 2011.
U.S.P.T.O. Notice of Allowance for U.S. Appl. No. 11/975,921, dated Dec. 14, 2011.
U.S.P.T.O. Notice of Allowance for U.S. Appl. No. 13/784,224 dated Sep. 18, 2014.
U. S. P. T. 0. Non-Final Office Action for U.S. Appl. No. 11/655,723, dated May 20, 2014.
U. S. P. T. 0. Non-Final Office Action for U.S. Appl. No. 13/437,604, dated Jul. 2, 2014.
U. S. P. T. 0. Non-Final Office Action for U.S. Appl. No. 13/437,604, dated Oct. 10, 2014.
Related Publications (1)
Number Date Country
20190321190 A1 Oct 2019 US
Provisional Applications (1)
Number Date Country
61766982 Feb 2013 US
Continuations (2)
Number Date Country
Parent 15351943 Nov 2016 US
Child 16192932 US
Parent 14185561 Feb 2014 US
Child 15351943 US